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Chapter 1 
Synthesis of Peptide-Substituted Norbornenyl Polymers as Fibronectin Mimics 
by Ring-Opening Metathesis Polymerization 
Abstract 
Synthetic fibronectin mimics have been constructed usmg functionalised norbomenyl 
polymers synthesized via ring-opening metathesis polymerization (ROMP). The ROMP 
reactions were catalyzed by newly developed ruthenium initiators. Prior to the synthesis of the 
fibronectin mimics, the polymerization reactions of a number of norbornene derivatives with 
pendent glycine or penta( ethylene oxide) (E05) units were studied in order to select the 
derivatives with optimal characteristics: high yields, fast polymerization times, and narrow 
PDI's. For these initial studies Ru=CHPh(Cb)(PCy3)2 (1) was used as the initiator. Based on 
these studies poly(5-norbomene-2-carboxyl) and poly( 4-(Exo-3,5-dioxo-1 O-oxa-4-aza-
tricyclo[5.2.l.O]dec-8-en-4-yl)-butyric acid) were chosen as the ideal backbones for a series of 
polymers functionalised with pendent arginine-glycine-aspartic acid (RGD) and serine-arginine-
asparagine (SRN) oligopeptides. The polymers containing a propyl spacer between the pendant 
group and the backbone were synthesized in an attempt to demonstrate that the presentation of 
the peptide units could be altered to closely mimic the natural presentation of these peptides in 
fibronection. Homopolymers and random copolymers containing various combinations of 
norbomene monomers with pendant £05 (21 & 14), GRGD/RGD (24 & 29), and SRN (25 & 30) 
units were made. Copolymers with large RGD or SRN contents ( > 10 mol %) could only be 
synthesised in high yields and narrow PDI's by using the newly developed ruthenium 2,3-
dihydroimidazolylidene initiators Ru=CHPh(Cl)2(PCy3)(DHIMes) (2) or Ru=CH-
CH=CH2(CH3)2(Cl)2(PCp3)(DIHMes) (3). In addition, the ROMP reactions of the norbornene 
monomers containing the propyl spacers also required the new initiator 2. Attempts to 
synthesize these polymers using ruthenium initiator 1 resulted in either low yields, bimodal 
molecular weight distributions, or a combination of both. 
Introduction 
Integrins and extracellular matrix proteins, such as fibronectin, together provide cells 
with adhesion and signaling pathways. 1 Many integrins recognize proteins that contain the short 
peptide sequence Arg-Gly-Asp (RGD).2 In fact, RGD alone has been shown to promote cell 
adhesion.3 Since cell attachment mediated by integrin-protein interactions influences cell 
survival, differentiation, and migration, this sequence has been targeted to study integrin function 
and provide treatments for diseases.4 For example, fibronectin and RGD containing peptides and 
2 
mimetics have been shown to have anti-metastatic activity, and thus may be good prospects for 
tumor therapy.5 
Although RGD itself promotes cell adhesion, it is significantly less active than 
fibronectin, suggesting that other sites in the protein act in synergy to the tripeptide. For 
example, RGD demonstrates significant losses in activity and estimated binding affinity in cell 
adhesion assays compared to fibronectin. 6 This observation led to the discovery of a synergy 
site on fibronectin, Pro-His-Ser-Arg-Asn (PHSRN), that enhanced RGD binding to cx 1 ~ 5 • 7 
Interestingly, PHSRN acted in synergy only when covalently bound by RGD.7 Deletion studies 
determined that Arg was the important residue for function, 7 suggesting that the sequence could 
be further truncated to SRN yet still retain its synergistic activity. The crystal structure of 
fibronectin confirmed that PHSRN was held on the same face , 30-40 A away from RGD, 
demonstrating that a single integrin molecule could access both sites. 8 Despite these findings , 
the majority of biomaterials containing RGD do not contain the synergy site, which could 
potentially enhance the cell binding ability. 
Synthetic polymers containing pendent RGD and SRN9 units would have many 
advantages over existing materials in terms of integrin binding strength coupled with ease and 
versatility of synthesis. The SRN would be covalently bound on the same molecule as RGD, 
which is necessary to obtain the synergistic activity. 7 Therefore, polymers containing both RGD 
and SRN should have increased cell binding activity compared to materials containing only 
RGD. The polymers would have many pendent RGD and SRN sequences per polymer chain, 
possibly leading to multivalent interactions and stronger binding. It has been shown that 
polypeptides containing RGD repeats have a greater cell binding ability than RGD itself, 
suggesting that having multiple integrin binding sites is advantageous. 10 The polymers would 
have slower clearance rates than small-molecule peptides, increasing the lifetime of the material 
in vivo. 10 Furthermore, unlike small molecule peptides and mimetics, polymers may be passive 
targets for such applications as tumor therapy. 11 
A synthetic polymer with RGDS units linked to a poly(carboxyethylmethacrylamide) 
backbone has been reported and shown to more effectively inhibit metastasis compared to the 
GRGDS peptide. 12 However, this polymer did not contain the synergy site and therefore did not 
inhibit cancer cell invasion into reconstituted basement membrane more than GRGDS. 
Additionally, this polymer was synthesized by nonliving, radical polymerization (resulting in 
3 
PDI's between 2 and 4.6) , which would make the synthesis of copolymers or block copolymers 
difficult. 
Gly-Arg-Giy-Asp-OH Ser-Arg-Asn-OH 
Synthetic Fibronectin Mimetic 
Ring-opening metathesis polymerization (ROMP) provides a better alternative for 
producing well-defined copolymers as fibronectin mimetics. The copolymer composition is 
readily controlled by the feed ratios of the monomers, 13 and ROMP of strained systems can be 
living, so block copolymers may be made. In addition, the polymer architecture can be readily 
altered, for example to include a spacer group between the peptide and polymer backbone. Our 
approach is to synthesize various synthetic polymers with pendent RGD, SRN9, and/or 
penta(ethylene oxide) (E05) units by ROMP for use in a variety of disease related applications 
and fundamental studies of fibronectin-a 1 ~ 5 binding (see Fibronectin Mimetic). Polymers 
containing RGD and SRN have the advantages already discussed. Since it has been shown that 
surfaces of oligo(ethylene oxide) are protein resistant14, copolymers containing E05 units were 
made. These may be more biocompatible as well as water soluble compared to the polymers 
containing only the peptides. 
ROMP of monomers with pendent amino acids has been previously demonstrated. We 
have synthesized polyethers 13 and others have synthesized polynorbornenyl 15 polymers with 
pendant amino acids. In these cases, the pendant groups were composed of one or two amino 
acids with alkyl side chains, containing no functionality. In addition, the norbornenyl polymers 
were synthesized with the less functional group tolerant molybdenum catalysts. In order to 
synthesize homo and copolymers with complex, biologically active groups using ruthenium 
based catalysts, we needed to explore the synthesis conditions, especially the choice of catalyst 
and monomer. 
4 
The polymers in this research were synthesized using well-defined ruthenium catalysts 1-
3. Catalyst 1 has been extensively explored and has proven to be both active for ROMP and to 
have extraordinary functional group tolerance. 16 We also recently reported catalyst 2 and 3. 17 
Although they have not yet been studied extensively in the ROMP reaction, these extremely 
active catalysts have been used with great success in ring-closing and cross metathesis 
reactions. 17 Due to the multitude of functional groups found in biologically relevant molecules 
such as RGD and SRN, the utility of the dihydroimidazolylidene catalysts 2 and 3 were explored 

















Mes = mesityl 
Cy = cyclohexyl 
Cp = cyclopentyl 
The synthesis of GRGD and SRN containing homo and copolymers is reported. Initially, 
polymers with different norbomeneyl backbones and one pendent amino acid were synthesized 
and compared. Out of the group of polymers studied, polymers 20 and 13 with pendent glycine 
units demonstrated the best characteristics in terms of ease and yield of synthesis coupled with a 
narrow, monomodal molecular weight distribution. Accordingly, the fibronectin mimics were 
synthesized using these backbones. RGD (24, 29), SRN (25, 30), and penta(ethylene glycol) (21, 
30) norbomene monomers were made and polymerized, and the resulting homo and copolymers 
were deprotected and characterized. Initiators 1, 2, and 3 were compared in terms of yields, 
molecular weight distribution, and trans to cis ratios of the resulting polymers Application of the 
more active initiators, 2 and 3 was necessary to obtain high yields of polymers containing larger 
than 10 mol% pendent RGD. Using the newly developed initiators 2 and 3, novel fibronectin 
mimetics, containing both RGD and the synergy site SRN were synthesized. 
5 
Results and Discussion 




X= 0 (4) 




X= Q (6) 
x = CH2 (7) 
iv 
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x = 0 : R = CH2COOCH3 (9) 
R = CH(CH3)COOCH 3 (10) 
R = CH2CH200CCH(CH3)NH-COOC(CH3)3 (11) 
R = CH2CH20CH2COOCH3 (12) 
R = CH2CH2CH2CONHCH2COOCH3 (13) 
R = CH2CH2CH2CO(OCH2CH2)50H (14) 
x = CHi R = CH2COOCH 3 (15) 
R = CH(CH3)COOCH3 (16) 
R = CH2CH200CCH(CH3)NH-COOC(CH3)3 (17) 
a Reaclion Conditions : i. H 2NCH2CH20H in THF/MeOH, 50 PC. ii . Boc-Aia-OH. DCC, and DMAP in CH2CI2 (11, 17). iii. Br-CH2COOCH 3, K2C03, 
and Bu 4NBr in DMF (12) . iv. CIH-Giy-OCH3 or CIH-Aia-OCH3 and Et 3N in CH2CI2. refiux (9 , 10, 15, 16). v. H2N(CH2)3COOH in THF/MeOH, 50 PC . 
vi. CIH-Giy-OCH 3, E13N, EDC, and HOBT in CH 2CI 2 (13) . vii. a) Oxalyl Cl and DMF inCH 2CI2; b) H(OCH2CH2)50H and K2C03 in THF, refiux ( 14). 
Monomer Synthesis. A series of monomers with one pendent amino acid or E05 was 
synthesized in order to study the ROMP of these monomers. In the past, simple glycine and 
alanine monomers 9, 10, 15, and 16 (Scheme 1) were synthesized in our group, but the yields of 
the reactions were relatively low (1 0 - 50%). Therefore the screening for monomers continued 
with the synthesis of norbornenes with a pendent glycine (19 and 20) or penta(ethylene glycol) 
unit (21) (Scheme 2). 
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i, ii £t?-R 
R = NHCH2COOCH 3 endo (19), 
exo (20) 
R = (OCH2CH2)50H (21) 
~NHCH2COOCH3 
(23) 
a Reaction conditions: i. CIH-Giy-OCH 3, Et3N, EDC, and HOST in 
CH 2CI2 (19, 20, 23). ii. a) Oxalyl Cl and DMF in CH2CI 2; b) 
H(OCH2CH2)50H and K2C03 in THF, reflux (21). 
These monomers were made in somewhat better yields in comparison to the imide-derived 
monomers. Glycine methyl ester hydrochloride was coupled to endo or exo 5-norbornene-2-
carboxylic acid (18) with EDC, triethylamine, and HOBT in CH2Ch in 66.0% (19) and 72.9% 
(20) yields, respectively. The same procedure was followed to synthesize monomer 23 from 22 
in 65% yield. The E05 monomer (21) was synthesized in 52.6% yield by reacting 
penta(ethylene glycol) with norbornene-cis-2-carboxylic acid chloride in the presence of base in 
anhydrous THF. 
Next, the synthesis of monomers with ethyl and propyl spacer groups between the 
norbornenyl group and amino acid (Scheme 1) was undertaken. First, 4 and 5 were heated to 50 
OC with 2-aminoethanol for 12 hours in a mixture of THF and MeOH to give the resulting 
alcohols 6 and 7 in 36.1% and 44.4% yields respectively. Then monomer 12 was synthesized in 
7 
49% yield by m1xmg 6 and methyl bromoacetate with potassium carbonate and tetrabutyl 
ammonium bromide in anhydrous DMF. Monomers 13 and 14 with propyl spacers were 
synthesized in decent yields from 8. The acid (8) was synthesized first in 40.5% yield by heating 
4 and aminobutyric acid in THF and MeOH at 50 OC for 12 hours. Monomer 13 was made as for 
19 and 20 in 56.6% yield, and monomer 14 by using the same procedure as for 21 except the 
acid chloride was generated in situ using oxalyl chloride and base in a 36% over-all yield. 
Finally, the GR(Pbf)GD(OtBu)-OH and S(OtBu)R(Pbf)N(Trt)-OH containing monomers 
(24, 25, and 29) were synthesized. 24 and 25 were created by initially synthesizing the peptides 
on a 4-carboxyltrityl linker resin using standard Fmoc chemistry, followed by coupling 18 to the 
amino terminus of the peptide. The monomer was then cleaved from the resin under mildly 
acidic conditions, giving the protected monomers in 76-97% and 92.1% yields respectively. In a 
similar manner, the R(Pbf)GD(OtBu)-OH and S(OtBu)R(Pbf)N(Trt)-OH monomers with propyl 
spacers (29 and 30) were synthesized in 82.9% and 85.2% yields respectively by coupling 8 to 
the amino terminus ofthe protected RGD and SRN peptides. 
Scheme 3. Synthesis of norbornene G-R(Pbf)-G·D(dBu)-OH and S(dBu)-R(Pbf)-N(Trt)-OH monomers.• 
0 
~OH + <;)-peptide 
Exo 18 
a Reaction conditions : i. a) HBTU, HOST, and DIEA in DMF; b) AcOH:CftCiiMeOH (5:41). 
Polymers with one pendent amino acid: synthesis and characterization. Before 
synthesizing polymers containing oligopeptides, polymers with one pendent amino acid or EOs 
group were studied. The polymers were synthesized by adding a solution of 1 in methylene 
chloride to a solution of monomer in methylene chloride to give an initial monomer 
concentration between 0.5 and 0.75 M. The mixtures were stirred vigorously for 15 minutes to 3 
8 
hours before quenching with ethyl vinyl ether. The polymers were precipitated into hexanes or 
ether, isolated by centrifugation, and dried under vacuum before characterization. Polymers with 
one pendent amino acid or E05 unit attached directly or through a spacer to the backbone were 
made and compared in terms of polymer yield, polymerization time, and polymer molecular 
weight distribution. Based on this comparison, norbomene and the propyl spacer imide-
derivative were selected for the synthesis of the more complex, oligopeptide systems due to their 
optimal characteristics. 
Table 1. Polymerization data for norbornenyl monomers with pendent amino acids. a 
Polymer Yield [M)o/[C)o Time Mn (x103)b PDib T9 (1>Cf Trans/ Carbene (ppm)d Free 
(min) Cisd PCy3?0 
Poly(9) 82% 100/1 30 17.7 1.19 147.6 2.4 18.67 no 
Poly(10) 83% 100/1 60 97.5 bimodal 
Poly(15) 90% 100/1 35 46.3 1.47 158.1 5.2 1948, 18.58 yes 
Poly(16) 95% 100/1 60 108 1.10 154.1 5.5 19.41 no 
Poly(20) 100% 50/1 45 10.9 1.15 88.0 2.4 19 02. 18.94, 18.74 yes 
Poly(21) 100% 36/1 35 4.61 1.12 ·48.9 3.6 19.07, 19.02, 18.72 yes 
Poly(23 ) 100% 100/1 <5 1.00 29.0 2.9 
•General reaction conditions : CH2CI2 as the solvent. rt. 1 as the initiator. [M]o = 0.5-0.75 M. bAll determined from GPC. CH 2CI 2 eluent, 
polystyrene standards except poly(20) with DMF as the eluent. poly( ethylene glycol) standards. coetermined from DSC. 10 PC/min. 2nd heat 
reported . dDetermined from 1H NMR. •oetermined from 31 P NMR. 
Polymers synthesized from monomers 9, 10, 15, and 16 were deterimined to be 
unsuitable for use in the more complex oligopeptide systems based on the results of previous 
studies. These monomers and polymers suffered from unfavorable characteristics such as low 
monomer yields and bimodal molecular weight distributions. Therefore the norbomene 
monomers were selected for further studies. 
Norbomene monomers (19-21 , 23) (Scheme 1) were polymerized and characterized (see 
Table 1 ). Since monomer 19 could be made from commercially available starting materials, it 
was synthesized and polymerized first. However, the reaction took 24 hours to reach 90% yield. 
This was not a surprising result since endo monomers contain less strain than the corresponding 
exo monomers and often take longer to polymerize. 18 Exo monomer 20 was then made and 
reacted quickly in 45 minutes to give a quantitative yield of polymer. The penta( ethylene glycol) 
monomer 21, also polymerized rapidly in 35 min. To determine if the polymer could be 
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synthesized even faster , the highly strained monomer, 23 , was polymerized. However, this 
monomer was too strained and polymerized quickly ( <5 minutes) and uncontrollably, resulting in 
an extremely broad molecular weight distribution (PDI of 29.0). 
Polymers, poly(20) and poly(21) where characterized (Table 1). The M11 ' s were 10 900 
([M]o/[C]o = 5011) and 4610 ([M]o/[C] o = 35/1) for poly(20) and poly(21) respectively and the 
PDI's were narrow (1.15 and 1.12). The polymers had very different glass transition 
temperatures depending on the substituent. The glycine substituent resulted in a polymer with a 
higher Tg compared to unsubstituted norbornene (88.0 OC vs. 31 OC1\ The flexible 
penta(ethylene glycol) units resulted in a more disordered polymer with a low Tg of -48.9 °C. 
Because of high yields of both monomer and polymer, facile synthesis, monomodal molecular 
weight distributions, and fast polymerization times, the norbornene olefin was chosen for the 
synthesis of the monomers and polymers with GRGD and SRN units. 
Table 2. Polymerization data for norbornenyl monomers with pendent amino acids attached through spacer units• 
Polymer Yield [M]o/(C)o Time Mn (x10lb PDib Tg (~CT Trans/ Carbene (ppm)d Free 
(min) Cisd PCy3?e 
Poly(12) 100% 75/1 150 66.2 1.31 86.1 2.3 18.70 no 
Poly(13) 81 % 50/1 30 74.5 2.8 18.68 no 
Poly(14) 100% 50/1 30 118 bimodal -29.9 2.9 18.69 no 
Poly(11) 100% 100/1 90 51 .9 1.07 96.8 2.3 18.68 no 
Poly(17) 95% 100/1 80 55.5 1.11 90. 3 5.5 1942, 19.20 yes 
"General reaction conditions: CH:!CI2 as the solvent, rt. 1 as the initiator, [M)o = 0.5-0.75 M. bAll determined from GPC, CH:!CI2 
eluent, polystyrene standards except poly(14) with DMF as the eluent, polystyrene standards. coetermined from DSC, 10 ~C/min , 2nd 
heat reported . dDetermined from 1H NMR. •oetermined from 31P NMR. 
In an attempt to alter the presentation ofRGD, polymers with ethyl (12) or propyl (13-14) 
spacer groups were synthesized and characterized (Table 2) concurrently with the norbornene 
monomers and polymers described above. Monomer 12 polymerized in 2.5 hours and 13 and 14 
in 30 minutes to give poly(12), poly(13), and poly(14) quantitatively. Again the Tg of the 
polymers depended on the substituents. Poly(12) and poly(13) had glass transitions lower than 
that of poly(9) with the glycine directly attached to the backbone (86.1 and 74.5 versus 147.6 
OC). This is due to the extra disorder created by the flexible alkyl spacer groups. Similar to 
poly(21), the penta(ethylene glycol) substituent resulted in poly(1 4) having a low glass transition 
10 
at -29.9 OC. The Mn ' s of poly(12) and poly(1 4) were 66 200 and 118 000. The molecular 
weight of poly(13) could not be determined due to the low solubility of the polymer. Poly(12) 
demonstrated a monomodal , molecular weight distribution of 1.31 while poly(1 4) had a 
biomodal PDI. The reason for this bimodal molecular weight distribution is unknown; only one 
propagating species was observable by 1H NMR. We attempted to saponify monomer 12 to 
yield the carboxylic acid functionality. But, similar to 15, saponification resulted in the 
regeneration of the 6. 
Polymers with pendant hoc-protected alanines, poly(ll) and poly(17) were synthesized in 
less than 2 hours in 100% and 95% yields respectively (Table 2). The molecular weight 
distributions were monomodal for both poly(11) and poly(17) , and the molecular weights were 
similar (Mn of 51 900 and 55 500 respectively). The polymers also exhibited similar glass 
transitions (96.8 and 90.3 OC). 
Polymers of 11 and 17 contain an alanine linked by the carboxylic acid rather than by the 
amine functionality to the polymer backbone. For the purposes of this research, peptides coupled 
to the polymer backbone through the amino terminus was desired. However, the synthesis of 
poly(ll) and poly(17) demonstrates the feasibility of attaching peptides through either termini , 
which may be useful for other types of applications. 
All of the previous polymerizations were monitored by NMR. The chemical shifts of the 
carbene propagating species, the presence of free phosphine, and the final trans/cis ratios (vide 
infra) are recorded in Tables 1 and 2. All of the initiated carbenes were broad multiplets . 
During the polymerization of the oxa-bridged monomers 11-14 only one propagating carbene 
was observed at roughly the same shift (between 18.67 and 18.70 ppm). Free phosphine was not 
observed in any of these reactions. However, methylene-bridged imide monomer 17 had two 
observable propagating species during polymerization (19.42 and 19.20 ppm) and the 
norbornene monomers 20 and 21 demonstrated three propagating species (at 19.02, 18.94, and 
18.74 ppm for 20, and 19.07, 19.02, and 18.72 ppm for 21). For these polymers, free phosphine 
was observed during the reaction. 
The presence of free phosphine and two propagating species during ROMP had been 
observed in a previous study, and it was determined that the monomer was coordinating to the 
ruthenium resulting in the observation of a monophosphine species in addition to the 
bisphosphine species?° For the above reactions, the presence of multiple propagating species 
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correlated to the observation of free phosphine during the reaction. Conversely, when free 
phosphine was not observed, only one propagating species was detected. This suggests that the 
multiple propagating species may be the monophosphine and bisphosphine species. 
Polymerization of the norbornene monomers resulted in three observable propagating species. 
The presence of an additional propagating species may be related to the asymmetry of the 
monomer. Even so, the presence of free phosphine and multiple propagating species during the 
reaction does not appear to have an observable detrimental effect on the final polymer 
characteristics, such as molecular weight distribution or reaction time. 
Polymers with pendent biologically relevant oligopeptides: synthesis and 
characterization. Polymers with pendant GRGD, SRN, and E05 were first synthesized using 
initiator 1 for 4 hours at room temperature in CH2Ch with an initial monomer concentration of 
0.7 M (Equation 1). In this way, monomers 21 and 24 with 10, 27, and 50 mol% GRGD in the 
feed as well as 100 mol% 24 and 100 mol% 25 were polymerized, and the protecting groups 
were cleaved with TF A. Only the polymerization with 10 mol% GRGD in the feed (26a) gave 
good results (Table 3) with a high over-all yield of 78% and a monomodal molecular weight 
distribution. Polymerizations with 27 mol% 24, 100 mol% 24, or 100 mol% 25 in the feed 
resulted in extremely low yields of polymer (less than 26%) presumably due to catalyst 
decomposition. Good yields (66%) were obtained for the polymerization with 50 mol% 24 in the 
feed, but the GPC trace revealed a bimodal molecular weight distribution of the polymer. Given 
these results, the more active catalysts, 2 and 3 were applied to the synthesis of these polymers. 
Polymerizations were carried out using initiators 2 and 3, and the characterization results 
for the polymers are given in Table 3. Few examples of these initiators used in ROMP have 
been reported. 21 However, the catalysts have been shown to be more active than 1 for ring-
closing metathesis and cross-metathesis, as well as being inter-changeable with each other at 
higher temperatures. 17•21 Based upon these initial studies, it was hoped and was found that these 
initiators would result in higher yields of the desired polymers. 
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1. 1, CH2CI2 , rt 
or 2 or 3, CH2CI2/ 
MeOH, 55 PC 
x, y, and/or z ~R ------~ ..... 
R = G-R(Pbf)-G-R(dBu)-OH (24), 




R = GRGD, SRN , 
and/or EOs 
( 1) 
Hompolymers and copolymers of 21 , 24, and 25 were synthesized (Equation I) using 2 or 
3 as initiators by heating the monomers in a I: I mixture of CH2Ch and MeOH in an oil bath at 
55 ·c for 2 hours with initial monomer concentrations of 0.6 M (homopolymers) or 0.7 M 
(copolymers) . A mixture of solvents was used to solubilize the polymers, and since the catalysts 
react faster at elevated temperatures, the mixtures were heated in sealed vials. The homopolymer 
of 24 (26c) was synthesized using initiator 3, and the rest were synthesized with 2. Copolymers 
with GRGD and E05 units, 26b (49 mol% GRGD), and with SRN and E05 units, 27a (53 mol% 
SRN), were synthesized. Fibronectin mimetics, copolymer 28a (32 mol% GRGD, 2I mol% 
SRN, and 47 mol% E05) and 28b (53 mol% GRGD and 47 mol% SRN) were also made. The 
amount of the peptide monomer incorporated into the polymer determined from 1H NMR 
corresponded to the amount in the feed for all of the copolymers. 
The protecting groups of the polymers were cleaved to yield the unprotected amino acids. 
All of the polymers except the SRN homopolymer (27b) were successfully deprotected using 
TF A. Polymer 27b was not fully deprotected by this acid; the polymer precipitated out of the 
TF A solution after I 0 minutes . Presumably, the more labile protecting groups (Pbf and Trt) 
were cleaved first altering the solubility of 27b in TF A, resulting in the precipitation of the 
polymer before the t-butyl groups were removed. However, all of the protecting groups of this 
polymer, including the t-butyl groups were cleaved using HF. The use of HF could be 
circumvented by changing the serine protecting group to the labile trityl group. 
All of the deprotected polymers were solublized in aqueous solution. Copolymer 26a, 
with 90.8 mol% penta(ethylene glycol) units, was the only polymer soluble in water immediately 
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after the deprotection steps. The rest of the polymers were solublized in water by stirring in 0.1 
N NaOH for 10 minutes, generating the sodium salt of the peptide carboxylic acid which was 
isolated by precipitation into methanol. For copolymers 26b and 27a this procedure cleaved off 
many of the penta(ethylene glycol) units (76% for 26b and 65% for 27a). However, it was later 
discovered that these polymers could also be made water soluble by direct treatment with milder 
bases such as dibasic phosphate buffer (pH 8), without saponifying the penta(ethylene glycol) 
units. 
The over-all yields (after polymerization, cleavage, and solubilization into water) of the 
polymers were all between 59 and 92% except for that of polymer 28b with a yield of 32% (see 
Table 3 ). The low yield of 28b was primarily due to polymer loss during the initial precipitation 
from the crude reaction solution. 1H NMR of all the crude reaction mixtures indicated that most 
of the monomers had been consumed. However, since the monomers and protected polymers 
had similar solubility, polymer purification proved difficult. Selective precipitation of the 
protected polymers was achieved by precipitating into mixtures of solvents such as CH2Ch/ether 
and MeOH/ether. The choice and relative amount of each mixture was different depending on 
the polymer. Polymer 26a was purified by Centriprep (MWCO 3000) using ethanol as the 
solvent.22 Regardless of the purification method, except for 28b, the yields were all good to 
excellent. 
Table 3. Polymerization data for norbomene monomers with pendent oligopeptide and EO 5 units• 
polymer Cata lyst %yield (M)o/[C]o mol% in feed mol% in polymerc M, PDf! T9 (1>C f Cis/ overall GRGD SRN E0 5 GRGD SRN E05 (x10
3)d Transc 
26ab 78% 20/1 10% 0% 90% 9.2% 0% 90.8% 18.7 1.13 -30.7 0.21 
26b 81% 20/1 50% 0% 50% 49% 0% 51% 15.91 1.13 52 .6 1.7 
26c 3 78% 10/1 100% 0% 0% 100% 0% 0% 13.3 1.32 98 .0 
27a 2 92% 20/1 0% 52% 48% 0% 53% 47% 17.29 1.21 62.3 1.6 
27b 2 74% 10/1 0% 100% 0% 0% 100% 0% 10.7 1.70 131 .2 
28a 2 59% 20/1 25% 25% 50% 32% 21% 47% 13.3 1.21 39.4 1.6 
28b 2 32% 10/1 50% 50% 0% 53% 47% 0% 11.8 1.26 104.6 
•General reaction conditions : CH 2CiiMeOH (1 :1) as the solvent, 55 PC for 2 hrs. in sealed vial, [Mh = 0.6-0.7 M. bReaction conditions: CH 2CI2 as 
the solvent, rt for 4 hrs ., [M)o = 0.7 M. ccalculated from 1H NMR. doetermined from GPC, pH 8.0 phosphate buffer eluent, poly( ethylene oxide) 
standards. •oetermined from DSC, 10 PC/min, 2nd heat reported. 176% of E05 repeats were saponified. 965% of E05 repeats were saponified. 
The GPC results are given in Table 3. The number-averaged molecular weights were 
fairly low between 10 700 and 18 700, and most importantly, the samples had monomodal 
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molecular weight distributions. Copolymer 27b had the broadest PDI value (1. 70). This was the 
only polymer to be deprotected by HF; the harsh deprotection conditions could have caused the 
molecular weight distribution to broaden from chain scission. However, the other samples had 
narrow PDI's between 1.13-1.32. Remarkably, the trimonomer copolymer, 28a, had a narrow 
PDI of 1.21. This result indicates that synthesizing more complex copolymers with four or even 
more monomers is possible so that drugs or reactive species may be incorporated into the 
polymers. The narrow PDI's also indicate that the synthesis of block copolymers may be 
possible. 
The Tg values of the copolymers varied depending on the substituents. For example, 
copolymers 26a & b had Tg values of -30.7 "C and 52.6 "C between that of homopolymers 
poly(21) at -48.9 "C and 26c at 98.0 "C. Copolymer 27a had a Tg of 62.3 "C while 
homopolymer 27b one of 131.2 "C. The trimonomer copolymer, 28a, with 53 mol% total 
peptide had a lower Tg (39.4 "C) than either of the dimonomer copolymers 26b and 27a which 
contained 49 mol% and 53 mol% peptide, respectively. This indicates that the presence of the 
third monomer introduces extra disorder. In addition, 28b had aT g of 104.6 T, which is close to 
that of the GRGD containing homopolymer, 26c. 
The large influence of the pendent groups on the T g of the polymers is extremely obvious. 
The SRN and RGD homopolymers exhibit fairly high glass transition temperatures compared to 
unsubstituted polynorbornene. Perhaps hydrogen bonding or other factors influenced the glass 
transition in these cases. Polymers containing the flexible penta( ethylene glycol) units exhibit 
lower Tg's. Depending on the substituent, the physical state of the polymer varied widely from 
an oil (poly(21)) to a powdery solid (26c, 27b, and 28b). 
Polymer Stereoisomers. The trans to cis ratios of the polymers synthesized in this 
research resulted in an interesting observation: polymers synthesized with 1 contained more 
trans olefins while those synthesized by 2 had slight excesses of cis olefins. The methylene-
bridged imide polymers had trans to cis ratios from 5.2/1 to 5.5/1 while the oxa-bridged imide 
polymers had ratios between 2.3/1 and 2.9/1. The poly(norbornene)s had ratios between 2.4/1 to 
3.611. The GRGD containing polymer 26a synthesized with 1 contained more trans olefins 
(trans/cis = 4.8/1 ). In contrast, the polymers synthesized with initiator 2, 26b, 27a, and 28a, 
contained a slight excess of cis olefins (cis /trans= 1.6/1 - 1.7/1, see Table 3). (Polymers 26c, 
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27b, and 28b were not soluble in CD30D and the olefin peaks of the isomers were not resolved 
in DzO.) 
To examine this further, monomers 15, 20, and 21 were polymerized under the same 
conditions with either 1 or 2 as the initiator. Polymerization of 15 with 1 resulted in a polymer 
with a trans to cis ratio of 5.2/1, while with 2 the ratio was equal (111). This trend was more 
marked with monomer 20, where 1 resulted in a polymer with a trans to cis of 2.4/1 and 2 
resulted in the reverse with a cis to trans of2.3/1. For 21, initiator 1 resulted in a polymer with a 
trans to cis ratio of 3.611 and 2 with a cis to trans ratio of 1.7/ 1. The results obtained from 
polymers polymerized by 2 are unusual considering that 1 usually results, as evidenced in this 
research, in predominantly trans polymers. The reason for this is under investigation. 
x+y 
R= 
1. 1, CH2CI2, rt 
or 2, CH2CI2/ 







R = RGD,SRN, 
and/or E05 
Polymers with spacer groups and pendent biologically relevant oligopeptides. To 
change the polymer architecture and the presentation of the oligopeptides, it is useful to be able 
to synthesize polymers with spacer groups between the peptide and the backbone. As a 
demonstration, monomers 14, 29 and 30 were polymerized to form polymers with propyl spacers 
between the backbone and pendent RGD, SRN and E05 (Equation 2). Initially, a series of 
homopolymers and random copolymers were synthesized using initiator 1, but the polymers 
obtained had bimodal molecular weight distributions (Table 4). In addition, they were found to 
have large number-averaged molecular weights ranging from 118 000 to 401 000. 
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Polymer % yielda [M]/[C] %RGD %SRN %EOs M0 (X l 0
3)b pDJb Tg(°Ct Trans/ 
Cis 
31 100% 50/I 0% 0% 100% 118 bimodal -29.9 2.9 
32 71% 20/1 100% 0% 0% 261 bimodal 93.7 2.3 
33a 94% 2011 0% 100% 0% 401 bimodal 53.8 1.1 
33b 85% 2011 0% 30% 70% 353 bimodal 50.2 3.7 
34d 90% lOll 20% 0% 80% 115 1.14 70.2 0.83 
"Calculated from 1H NMR. 6Mn and PDI determined from GPC, DMF eluent, polystyrene standards . 0 Determined 
from DSC, I 0°C/min, 2"d heat reported. dReaction conditions: CH2Cl2:MeOH ( I: I) as the solvent, 55°C for 2hrs. in 
sealed vial using initiator 2. Note: All other reactions were performed under the following conditions: CH2Cl2 as the 
solvent, rt for 4hrs. using initiator I. 
The E05 homopolymer 31 was soluble in water. The polymers 32, 33a, and 33b were 
deprotected with TF A, but unfortunately they were not soluble in water. Treatment of the 
deprotected polymers with pH 8 phosphate buffer or 0.1 M NaOH did not enhance their 
solubility. The polymers' large molecular weights were attributed as the reason for their poor 
solubility. In order to address the problem of bimodal molecular weight distributions and poor 
solubility, initiator 2 was employed to synthesize a smaller RGD I E05 random copolymer. 
Polymer 34 was synthesized as previously described using 2 as the initiator with a 
[M] 0/[C] 0 = 1011 (Equation 2). The yield was approximately 90% by 
1H NMR. The polymer 
was deprotected with TF A and rendered soluble in water by first dissolving in pH 8 phosphate 
buffer (which did not saponify any of the E05 units), then precipitating into methanol. The water 
solubility of this polymer demonstrates that the solubility of these types of polymers is strongly 
dependent upon their size. The amount of 29 incorporated into the polymer (30 mol%) was 
slightly higher than the amount in the feed (20 mol%). The Mn obtained in aqueous buffer was 
fairly high, at 115 000 and the PDI was narrow (1.14). The Tg of the polymer was 70.2 ·c and 
the cis to trans ratio was 1.211. This work is readily extended to the synthesis of other 
homopolymers and copolymers, and demonstrates that using the more active initiators, the 
polymer architecture can be altered to include spacer units. 
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Conclusions 
A series of polymers with pendant glycine or penta(ethylene glycol) units with various 
norbomenyl olefins was synthesized by using initiator 1, and the yields, molecular weights, 
PDI's, and Tg's were compared. From these results, it was apparent that norbornenes would be 
ideal for the synthesis of polymers with pendent biologically relevant peptides. In order to vary 
the polymer architecture, polymers with ethyl and propyl spacers between the backbone and 
pendent groups were also studied. 
Polymers with pendent RGD, SRN, and E05 were synthesized. The RGD and SRN units 
should mimic the activity of fibronectin, and the addition of E05 units may reduce the toxicity of 
the materials . When initiator 1 was employed in the synthesis, only the polymer containing 9.2 
mol% RGD was made in decent yield with a monomodal molecular weight distribution. In 
addition, the use of initiator 1 to synthesize the polymers containing propyl spacers between the 
polymer backbone and the peptide ligand resulted in bimodal molecular weight distributions. 
Ultimately, the synthesis of the polymers containing large amounts of peptide and the polymers 
with the propyl spacers required the use of the more active 2,3-dihydroimidazolylidene initiators 
2 and 3. 
One of the goals of polymer chemistry has been to mimic the complexity and diversity of 
nature. Using the more active initiators, polymers with two and even three different types of 
monomers (RGD, SRN, and penta(ethylene glycol) containing) were made. With this success, 
the possibility of synthesizing more complex polymers with four , five or more monomer units 
incorporated into one polymer is possible. For example, polymers with peptides and sugars to 
specifically target cells, growth factors to induce cell growth, and drugs may be possible. 
Polymers with groups that can react with gold or silica surfaces in addition to containing 
antibodies or other biological moieties may also be synthesized for use in sensor technology. By 
contrast, the simpler RGD and SRN containing polymers described in this paper may already 
provide diverse uses. For example, these polymers may be used for a variety of fundamental 
research studies of the binding of integrins to proteins and for many disease-related applications 
such as in tumor therapy. 
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Experimental 
Materials. 2-aminoethanol and solvents were purchased from EM science. Methylene 
chloride used in the polymerization reactions was dried over CaH2, degassed, and vacuum 
transferred before use. Glycine methyl ester hydrochloride was purchased from Sigma. 
Penta(ethylene glycol) was purchased from Aldrich and dried over 4 A molecular sieves (Linde). 
5-Norbornene acid-exo-2-carboxylic acid (exo 18)23 and acid chloride24 were synthesized 
according to literature procedures. The peptides were synthesized by the Beckman Institute 
Biopolymers Synthesis Laboratory (California Institute of Technology) using reagents purchased 
from NovaBiochem. Centriprep flasks were purchased from Millipore. All other chemicals 
were purchased from Aldrich and used as received. 
Techniques. All operations were carried out under a dry nitrogen or argon atmosphere. 
Dry box operations were performed in a nitrogen-filled Vacuum Atmospheres dry box . Column 
chromatography was performed using silica gel 60 (230-400 mesh) from EM science. 1H NMR 
spectra were recorded on a General Electric QE-300 (300.1 MHz) spectrometer, a JEOL GX-400 
(399.65 MHz) spectrometer, or a Varian UnityPlus 600 (600.203 MHz) spectrometer as 
indicated. 13C NMR (75.49 MHz) spectra were recorded on a General Electric QE-300 
spectrometer. Chemical shifts are reported downfield from tetramethylsilane (TMS). Infrared 
spectroscopy was performed on a Perkin Elmer Paragon 1000 FT-IR spectrometer using a thin 
film of sample cast on a NaCl plate or a KBr pellet as indicated. High-resolution mass spectra 
were provided by the Southern California Mass Spectrometry Facility (University of California, 
Riverside). Gel permeation chromatographs with CH2Ch as the eluent (flow rate of 1 mL/min) 
were taken using an HPLC system equipped with an Altex model 11 OA pump, a Rheodyne 
model 7125 injector with a 100 OL injection loop, two American Polymer Standards 10 micron 
mixed bed columns, and a Knauer differential refractometer and poly(styrene) the calibration 
standard. Aqueous GPC (0.1 M Na2HP04 dibasic buffer) or DMF (both with a flow rate of 1 
mL!min) were conducted using an HPLC system equipped with a Waters 515 HPLC pump, a 
Rheodyne model 7725 injector with a 200 OL injection loop, a Waters 2487 Dual A. absorbance 
detector, a Waters 2410 refractometer, two TSK columns (TASK 3000PW, TSK 5000PW) and 
poly( ethylene oxide) or polystyrene as the calibration standard as indicated. Differential 
scanning calorimetry was measured on a Perkin-Elmer DSC-7 for Tg' s above 25 ·c and on a 
Perkin-Elmer Pyris1 for Tg' s below 25 ·c. The results are given for the second heating using a 
scan rate of 10 ·c /min. The HPLC results were taken on a Beckman 126 Solvent Module HPLC 
equipped with a 166 UV Detector and an Altech 18-LL column using a H20 /CH3CN solvent 
system (7% CH3CN for 6 min, 7-90% CH3CN over 38 min, and 90% CH3CN for 8 min). 
Monomer Synthesis 
Exo-(3,5-dioxo-4-aza-tricyclo~5.2.1.02 '6]dec-8-en-4-yl)-acetic acid methyl ester (15). 
Literature procedureError! Bookmark not de med. was followed except that CH2Ch was used as solvent 
to give 15 in 58.5% yield as a white solid. 1H NMR (CDCh, 300 MHz) 8 6.29-6.30 (2H, m), 
4.22 (2H, s), 3.73 (3H, s), 3.30-3.32 (2H, m), 2.75 (2H, d, J = 1.5 Hz), 1.70 (lH, d, J = 9.9 Hz), 
1.52 (lH, d, J = 9.9 Hz). 
[ (Bicyclo[2.2.1 ]hept-5-ene-endo-2-carbonyl)-amino ]-acetic acid methyl ester (19). 
Triethylamine (1.41 mL, 10.1 mmol) and glycine methyl ester hydrochloride (636 mg, 5.06 
mmol) were added to a solution of endo 18 (700 mg, 5.06 mmol) in CH2Ch (75 mL). 1-
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Hydroxybenzotriazole (HOBT, 1.03 g, 7.62 mmol) was added and the solution was stirred until 
all solids had dissolved. Then a solution of 1-[3-( dimethylamine )propyl]-3-ethylcarbodiimide 
hydrochloride (EDC, 971 mg, 5.06 mmol) and triethylamine (1.41 mL, 10.1 mmol) in CH2Ch 
(25 mL) was added and the mixture was stirred for 24 h. The organic layer was washed 
successively with 10% citric acid, H20 , sat. NaHC03, and brine, dried over MgS04, and the 
solvent removed in vacuo . The crude product was subjected to column chromatography (ether) 
resulting in 704 mg (66% yield, 11% exo) of 19 as a white solid. 1H NMR (CD2Cb, 300 MHz) 8 
6.17-6.19 (lH, m), 5.94-5 .97 (lH, m), 3.92 (2H, d, J = 5.7 Hz), 3.70 (3H, s) , 3.14 (1H, bs), 2.87-
2.92 (2H, m), 1.85-1.93 (lH, m), 1.28-1.43 (3H, m). 13C NMR (CD2Cb, 300 MHz) 8 174.62, 
171.16, 138.03, 132.73 , 52.58 , 50.39, 46.77, 44.80, 43 .26, 41.46, 29.84. IR (NaCl plate) : same 
as for 20 (vide infra) . 
[(Bicyclo[2.2.1]hept-5-ene-exo-2-carbonyl)-amino]-acetic acid methyl ester (20). The 
same procedure as for 19 was followed with 1.4 mL (1 0.0 mmol) triethylamine, 541 mg ( 4.3 
mmol) glycine methyl ester hydrochloride, 565 mg ( 4.1 mmol) exo 18, 828 mg (6 .1 mmol) 
HOBT, and 785 mg (4.1 mmol) EDC in 40 mL ofCH2Cb resulting in 625 mg (72.9%) of20 as 
a off-white solid. 1H NMR (CDC13, 400 MHz) 8 6.10-6.13 (2H, m), 6.01 (1H, bs), 4.05 (2H, dd, 
J = 4.8 Hz, 17.9 Hz) , 3.75 (3H, s), 2.96 (lH, s), 2.91 (lH, s), 2.06-2.08 (1H, m) , 1.90-1.95 (lH, 
m), 1.67 (lH, d, J = 8.0 Hz), 1.34 (2H, d, J = 9.2). 13C NMR (CD2Cb, 300 MHz) 8 175.92, 
170.97, 138.48, 136.25 , 52.43 , 47.48, 46.45 , 44.49, 41.94, 41.42, 30.59. IR (NaCl plate) : 
3315.1 , 3059.3, 2957.1 , 2865 .0, 1747.1 , 1644.8, 1532.3, 1440.2, 1404.4, 1368.6, 1327.7, 1204.9, 
. l + 
1097.5, 1046.4, 1010.6, 898 .0, 852.0, 790.6, 719.0 em·. HRMS (EI) calcd for (M) 209.1052 
found 209.1 048. 
Bicyclo[2.2.1] hept-5-ene-exo-2-carboxylic acid 2-(2-(2-[2-(2-hydroxy-ethoxy)-
ethoxy]-ethoxy)-ethoxy)-ethyl ester (21). 5-Norbornene acid-exo-2-carboxylic acid chloride 
(1.2 g, 7.67 mmol) was added drop wise to a stirred mixture of penta(ethylene glycol) (2 .8 mL, 
13.2 mmol) and potassium carbonate (3.7 g, 26.8 mmol) in THF (160 mL) . The reaction was 
heated to reflux and stirred for 12 h, cooled, and the solvent removed in vacuo. H20 was added 
and the mixture was made neutral with 10% citric acid. The aqueous layer was washed with 
CH2Cb (3 times), the organic layers were then consolidated, dried over MgS04 and the solvent 
was removed in vacuo . The residue was subjected to column chromatography (EtOAc/MeOH, 
9/1) to give 1.4 g (52.6%) of21 as a colorless oil. 1H NMR (CDCh, 300 MHz) 8 6.07-6.14 (2H, 
m) , 4.23 (2H, t, J = 4.8), 3.58-3.73 (18H, m), 3.03 (lH, s), 2.90 (1H, s), 2.60 (lH, bs), 2.22-2.27 
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(1H, m), 1.88-1.94 (lH, m), 1.51 (lH, d, J = 8.4Hz), 1.32-1.38 (2H, m). C NMR (CDCl3, 300 
MHz) 8 176.01 , 137.87, 135.53, 72.34, 70.38, 70.12, 69.02, 63 .29, 61.45 , 46.47, 46.09, 42.83 , 
41.43 , 30.15. IR (NaCl plate): 3455 .7, 2936.8, 2864.2, 1721.2, 1451.4, 1342.5, 1332.1 , 1280.2, 
1254.3 , 1228.9, 1171.2, 1109.0, 1051.9, 942.9, 859.9, 719.8 cm- 1. HRMS (DCI/NH3) calcd for 
(MHt 359.2070 found 359.2082. 
[(Tricyclo[4.2.1.02'5]non-7-ene-exo-3-carbonyl)-amino]-acetic acid methyl ester (23). 
Same procedure as for 19 was followed with 973 f.!L (6.98 mmol) triethylamine, 438 mg (3.49 
mmol) glycine methyl ester hydrochloride, 573 mg (3.49 mmol) 22, 708 mg (5.22 mmol) HOBT, 
and 669 mg (3.49 mmol) EDC in 30 mL CH2Cl2. The crude product was subjected to column 
chromatography (ether) to provide 534 mg (65%) of23 as a white solid. 1H NMR (CDCh, 300 
MHz) 8 5.90-5.98 (2H, m), 4.04 (2H, d, J = 5.1 Hz), 3.74 (3H, s), 2.71 (1H, s), 2.65 (1H, s), 
2.31-2.36(2H, m), 2.14 (1H, t, J = 7.2 Hz), 1.99 (1H, t, J = 7.8 Hz), 1.54-1.66 (2H, m), 1.32 (lH, 
d, 1 = 9.3 Hz). 13C NMR (CDCh, 300 MHz) 8 175 .68, 170.59, 135.75, 134.39, 52.22, 43 .97, 
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43.85, 41.16, 40.35 , 40.28 , 38.70, 34.12, 23.68. IR (NaCI plate): 3287.8, 3062.8, 2966.4, 2355.9, 
1754.9, 1647.8, 1540.7, 1433.6, 1369.3 , 1203.3, 1048.0, 989.0, 699.9, 507.1 cm- 1. HRMS (DEI) 
calcd for (M+) 235.1208 found 235.1201 
4-Hydroxymethyl-1 0-oxa-4-aza-tricyclo [ 5.2.1.02'6] dec-8-ene-exo-3,5-dione ( 6). 
Prepared as for the 7 (vide infra) with 6.1 g (36.8 mmol) 4 and 2.0 mL (36.8 mmol) of 2-
aminoethanol in THF/MeOH (30 mL, 111) resulting in 2.78 g (36.1%) of6 as a white crystalline 
solid. 1H NMR (D20, 500 MHz) 8 6.48 (2H, s), 5.17 (2H, s), 3.56 (2H, t, J = 4.5), 5.50 (2H, t, J 
= 4.5), 2.99 (2H, s). 13C NMR (D20, 300 MHz) 8 179.32, 136.28, 80.83 , 58.12, 47.31, 40.87. 
IR (KBr pellet): 3475, 3001, 2969, 2931 , 2894, 1766, 1688, 1438, 1407, 1386, 1335, 1316, 
1268, 1219, 1169, 1155, 1099, 1054, 1014,956,938,915,878,849,810,773,723,704,653,597 
cm-1. HRMS (DCI/NH3) calcd for (MHt 210.0766 found 210.0763. 
(Exo-3,5-dioxo-1 0-oxa-4-aza-tricyclo [ 5.2.1.02'6] dec-8-en-4-ylmethoxy )-acetic acid 
methyl ester (12). Methyl bromoacetate (1.81 mL, 19.1 mmol) was added to a solution of the 6 
(1 g, 4.78 mmol), potassium carbonate (796 mg, 5.76 mmol) , and tetrabutylammonium bromide 
(20 mg, 0.059 mmol) in anhydrous DMF (20 mL) . The solution was stirred at room temperature 
for 12 h. CHCh (100 mL) was added, and the organic layer was successively washed with H20 
(twice) and 5% HBraq. The aqueous layers were combined and washed with CH2Ch (three 
times). All of the organic layers were pooled, dried over MgS04, and the solvent was removed 
in vacuo. The crude product was recrystallized from a mixture of EtOAc and ether ( 4:1) to give 
661 mg (49%) of 12 as a white solid. 1H NMR (CDC~) , 300 MHz) 8 6.51 (2H, s), 5.27 (2H, s), 
4.62 (2H, s), 4.34 (2H, t, J = 5.4 Hz), 3.81 (2H, t, J = 4.5 Hz), 3.78 (3H, s), 2.89 (2H, s). 13C 
NMR (CDC~), 300 MHz) 8 175.87, 167.66, 154.36, 136.44, 80.81, 63.35, 52.27, 47.39, 37.46. 
IR (NaCl plate): 3009.3 , 2966.4, 2355.9, 1754.9, 1701.3, 1428.2, 1396.1, 1337.1 , 1288.9, 1214.0, 
1149.7, 1122.9, 1021.2, 919.4, 876.6, 849.8, 785.5, 721.3, 646.3, 592.7 cm-1• 
2-tert-Butoxycarbonylamino-propionic acid exo-3,5-dioxo-1 O-oxa-4-aza-
tricyclo[5.2.1.02,6]dec-8-en-4-ylmethyl ester (11). The same procedure as for 17 (vide infra) 
was followed with 500 mg (2.39 mmol) of the 6, 453 mg (2.39 mmol) ofN-tert-butoxycarbonyl-
L-alanine, 494 mg (2.39 mmol) of DCC, and 44 mg (0.359 mmol) of DMAP in 20 mL CH2Ch. 
The product was purified by recrystallization from MeOH/hex (211) to yield 457 mg (50.3%) of 
11 as white crystals. 1H NMR (CDCh, 500 MHz) 8 6.51 (2H, s), 5.27 (2H, s), 5.02 (lH, bs), 
4.30 (2H, t, J = 5.3 Hz), 4.23-4.29 (lH, m), 3.73-3.81 (2H, m), 2.86-2.89 (2H, m), 1.42 (9H, s), 
1.34 (3H, d, J = 7.2 Hz). 13C NMR (CDCh, 300 MHz) 8 175.91, 172.76, 154.97, 136.44, 80.79, 
61.17, 49.06, 47.38, 47.36, 37.63, 28.23, 18.25. IR (NaCl plate): 3356.0, 2967.3, 2936.6, 
1742.0, 1701.1, 1511.8, 1455.6, 1430.0, 1394.2, 1363.5, 1332.8, 1251.0, 1158.9, 1066.8, 1020.8, 
886.0, 855.4, 713.9, 647.4. HRMS (DCI/NH3) calcd for (MHt 381.1662 found 381.1645. 
2-tert-Butoxycarbonylamino-propionic acid exo-3,5-dioxo-4-aza-
tricyclo[5.2.1.02'6]dec-8-en-4-ylmethyl ester (17). 7 (300 mg, 1.45 mmol), N-(tert-
butoxycarbonyl)-L-alanine (2.74 mg, 1.45 mmol), 1 ,3 -dicyclohexylcarbodiimide (DCC, 299 mg, 
1.45 mmol), and 4-(dimethylamino)pyridine (DMAP, 27 mg, 0.22 mmol) were stirred in CH2Ch 
(18 mL) for 12 hours. The solution was filtered and the solvent removed in vacuo. The residue 
was subjected to column chromatography twice (EtOAc, followed by EtOAc/hex, 8/2) to give 
334 mg (60.9% yield) of 17 as a sticky solid. 1H NMR (CD3Cl, 500 MHz) 8 6.29 (2H, s), 4.99 
(lH, bs), 4.11-4.32 (3H, bm), 3.75-3.79 (2H, m), 3.29 (2H, d, J = 10.1 Hz), 2.71 (2H, s), 1.52-
1.54 (1H, m), 1.43 (9H, s), 1.35 (3H, d, J = 7.2 Hz), 1.27-1.29 (lH, m). 13C NMR (CDCh, 300 
MHz) 8 177.89, 173.33, 155.33, 137.79, 79.87, 61.69, 49.33, 47.83, 45 .22, 42.73, 37.49, 28.31, 
18.39. IR (NaCl plate): 3366.2, 2977.5 , 2936.6, 1747.1, 1696.0, 1506.7, 1450.4, 1389.1, 1363.5 , 
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1327.7, 1251.0, 1164.0, 1061.7, 990.1, 775.3, 719.0, 642.3 cm-1• HRMS (DCI/NH3) calcd for 
(MH)+ 379.1869 found 379.1871. 
4-(Exo-3,5-dioxo-1 0-oxa-4-aza-tricyclo [5.2.1.02'6] dec-8-en-4-yl)-butyric acid (8). 
Same procedure as for the synthesis of the 7 was followed with 3 g (18 mmol) 4 and 1.86 g (18 
mmol) 4-aminobutyric acid in THF/MeOH (36 mL, 1:1). The crude product was subjected to 
column chromatography (EtOAc with 3% AcOH) to give 1.83 g (40.5%) of 8 as a white solid. 
1H NMR (CDCi), 300 MHz) 8 6.51 (2H, s), 5.26 (2H, s), 3.56 (2H, t, 1 = 6.9 Hz), 2.85 (2H, s), 
2.34 (2H, t, 1 = 7.5 Hz), 1.90 (2H, t, 1 = 7.2 Hz). 13C NMR (CDCi], 300 MHz) 8 176.01, 168.60, 
136.51 , 80.95, 47.40, 37.96, 30.81 , 22.59. IR (NaCl plate): 3480.6, 2977.1, 2677.2, 2495.1, 
2355.9, 1770.9, 1696.0, 1562.1, 1396.1, 1165 .8, 1096.1 , 1015.0, 914.1, 871.2, 849.8, 807.0, 
721.3, 651.6, 603.4 cm- 1• HRMS (DCI/NH3) calcd for (MHt 252.0872 found 252.0878. 
[ 4-(Exo-3,5-dioxo-1 0-oxa-4-aza-tricyclo [ 5.2.1.02'6] dec-8-en-4-yl)-butyrylamino]-
acetic acid methyl ester (13). Same procedure as for 20 was followed with 2.21 mL (15.8 
mmol) triethylamine, 645 mg (4.77 mmol) HOBT, 609 mg (3.18 mmol) EDC, 400 mg (3.19 
mmol) glycine methyl ester hydrochloride, and 800 mg (3.18 mmol) of8 in 64 mL CH2Ch. The 
crude product was subjected to column chromatography (EtOAc) to give 580 mg (56.6%) of 13 
as a white solid. 1H NMR (CDC13, 300 MHz) 8 6.53 (2H, s), 5.28 (2H, s), 4.05 (2H, d, 1 = 5.1 
Hz), 3.76 (3H, s), 3.62 (2H, t, 1 = 6.3 Hz), 2.86 (2H, s), 2.19 (2H, t, 1 = 6.9 Hz), 1.97 (2H, t, 1 = 
6.3 Hz). 13C NMR (CD2Ch, 300 MHz) 177.09, 172.47, 136.98, 81.56, 54.68, 52.64, 47.99, 
41.66, 38.42, 33.39, 24.22. IR (NaCl plate): 3563.8, 3292.9, 3084.6, 2949.2, 2355.5, 1750.7, 
1698.6,1547.6, 1433.0, 1401.8, 1370.5, 1282.0, 1214.3, 1162.2, 1021.6, 917.4, 875.0, 849.7, 
802.9, 719.5, 651.8, 589.3, 500.8 cm- 1• HRMS (EI) calcd for (MH)+ 323.1243 found 323.1241. 
4-(Exo-3,5-dioxo-1 0-oxa-4-aza-tricyclo [ 5.2.1.02.6] dec-8-en-4-yl)-butyric acid 2-(2-(2-
[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy)-ethoxy)-ethyl ester (14). The acid chloride of 8 was 
generated in situ using 700 mg (2.78 mmol) of 8, 530 1-1L (6.12 mmol) oxalyl chloride, and a 
catalytic amount of DMF in CH2Ch following a literature procedure?
4 To a solution of the 
crude acid chloride in anhydrous THF (45 mL), penta(ethylene glycol) (662 mg, 2.78 mmol) and 
potassium carbonate (1.31 g, 9.47 mmol) were added. The mixture was heated to reflux and 
stirred for 12 h. After cooling to room temperature, CH2Ch (50 mL) was added, and the organic 
layer was washed with H20 (three times). The organic layer was dried over MgS04, and the 
solvent was removed in vacuo. The crude product was subjected to column chromatography 
(EtOAc/MeOH, 4/1) to give 477 mg (36%) of 14 as a yellow oil. 1H NMR (CDCh, 300 MHz) 8 
6.51 (2H, s), 5.24 (2H, s), 4.21 (2H, t, 1 = 4.8 Hz), 3.64-3.66 (18H, m), 3.53 (2H, t, 1=6.9 Hz), 
2.84 (2H, s), 2.32 (2H, t, 1=7.5 Hz), 1.88 (2H, t, 1=7.1 Hz). 13C NMR (CD2Cl2, 300 MHz) 8 
176.80, 173.01' 136.99, 81.50, 73.04, 71.01 ' 70.96, 70.79, 69.53, 64.14, 62.09, 47.96, 38.34, 
31.49, 23.27. IR (NaCl plate): 4015.1, 3479.7, 2878.7, 1947.7, 1767.4, 1734.6, 1696.4, 1636.3, 
1439.6, 1401.4, 1352.2, 1100.9, 1019.0, 953.4, 876.9, 718.5, 647.5, 587.4 cm- 1• HRMS 
(DCI/NH3) calcd for (MNH4t 489.2448 found 489.2460. 
Norbornene G-R(Pbf)-G-D(01Bu)-OH monomer (24). G-R(Pbf)-G-D(01Bu)-resin 
(0.5 mmol peptide, 4-carboxytrityl linker Novasyn® resin) was placed in a flask containing a frit 
and stopcock. The resin was swelled in 16.7 mL of DMF for 15 min and then rinsed with DMF 
(1 x 10 mL). In a vial, 276 mg (2.0 mmol) of exo 18, 758 mg (2.0 mmol) of 2-(1 H-
benzotriazole-1-yl)-1, 1 ,3,3-tetramethyluronium hexaflurophosphate (HBTU), and 270 mg (2.0 
mmol) of HOBT in 16.7 mL of DMF were agitated until all solids had dissolved. N,N-
diisopropylethylamine (DIEA) was added (695 IJ.L, 4.0 mmol) and the solution was agitated and 
pipetted onto the resin. Nitrogen was gently bubbled through the mixture for 2 h. The resin was 
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then rinsed with DMF (5 x 10 mL), CH2Ch (5 x 10 mL), and MeOH (5 x 10 mL) and dried for 
24 hat 30 millitorr. In a vial , 33 mL of acetic acid, CH2Ch, and MeOH (5:4:1) were added to 
the dry resin and the vial was periodically swirled for 1.5-2 h. The solution was filtered to 
remove the resin, added to an excess of hex, and the solvent was removed in vacuo. The 
procedure was repeated to remove all of the acetic acid. The product was freeze-dried from 
benzene to give 24 in 76-97% yield as an off-white solid. HPLC : single peak at 21.94 min. 1H 
NMR (CD2Ch, 600 MHz) 8 7.89 (lH, bs), 7.50 (1H, bs), 7.42 (1H, bs), 7.06 (lH, bs), 6.21 (2H, 
bs), 6.03 (lH, s), 5.99 (lH, s), 4.65 (lH, bs), 4.38 (lH, bs), 3.96 (lH, bs), 3.87 (2H, bs), 3.75 
(1H, bs) , 3.13 (2H, bs) , 2.88 (2H, s) , 2.83 (lH, s), 2.78 (lH, s), 2.71 (2H, bs) , 2.46 (3H, s), 2.40 
(3H, s) , 2.07 (lH, bs), 1.99 (3H, s) , 1.80 (1H, bs), 1.72-1.75 (lH, m), 1.63 (lH, bs), 1.48-1.52 
(3H, m) , 1.35 (6H, s) , 1.29 (9H, s), 1.17-1.22 (2H, m). NOESY cross peaks (CD2Ch, 600 MHz) 
8 7.89 (G2NH) , 4.38 (Ra); 7.50 (DNH), 3.96 (G2a), 3.75 (G2a); 7.42 (RNH), 3.87 (G 1a); 7.06 
(G 1 NH), 2.07 (norbornene). TOCSY cross peaks (CD2Ch, 600 MHz) 8 norbornene: 6.03 , 5.99, 
2.83 , 2.78 , 2.07, 1.72-1.75, 1.48-1.52, 1.17-1.22; Gl: 7.06, 3.87; R: 7.42, 4.38, 3.13, 1.80, 1.63 , 
1.48-1.52; Pbf group: 2.88, 2.46, 2.40, 1.99; 02: 7.89, 3.96, 375; D: 7.50, 4.65 , 2.71. 13C 
NMR (CD2Ch, 300 MHz) 8 178.01, 173.79, 173.58, 171.27, 170.64, 170.44, 159.11 , 156.99, 
138.60, 138.33 , 136.42, 132.84, 132.64, 128.64, 125.19, 117.82, 86.87, 81.96, 71.73 , 70 .68, 
70.28, 69.07, 66.95 , 49.77, 47.54, 46.52, 44.31, 43.43, 41.96, 37.59, 30.77, 28.66, 28.12, 25 .68, 
19.48, 18.15, 12.57. IR (NaCl plate): 3445.2, 3310.3, 3050.9, 2967.9, 2936.7, 1726.4, 1638.2, 
1544.8, 1456.6, 1368.4, 1291.5, 1245.2, 1152.8, 1101.4, 1029.5, 956.1, 899.6, 848.2, 807.1 , 
786.6, 704.4, 668.4, 560.5 em·'. HRMS (DCM/NBA/NaCl) calcd for (MNat 854.3735 found 
854.3707. 
Norbornene S(01Bu)-R(Pbf)-N(Trt)-OH Monomer (25). The same procedure as for 
24 was followed with S(01Bu)-R(Pbf)-N(Trt)-resin (0.75 mmol , 4-carboxytrityllinker Novasyn® 
resin), 471 mg (3 .0 mmol) of exo 18, 1.14 g (3.0 mmol) ofHBTU, 405 mg (3 .0 mmol) ofHOBT, 
and 1.0 mL (6.0 mmol) of DIEA in 18.9 mL of DMF to yield 723 mg (92.1 %) of 25 as a fluffy, 
white solid. HPLC: single peak at 28.86 min. 1H NMR (CD2Ch, 600 MHz) 8 7.54 (lH, bs), 
7.38 (1H, bs), 7.07-7.13 (15H, m), 6.46 (1H, bs), 6.01-6.03 (3H, m), 5.84 (lH, bs), 4.65 (lH, bs), 
4.52 (lH, bs), 4.37 (1H, bs), 3.62 (1H, bs) , 3.37 (1H, bm), 3.15 (1H, bs) , 2.92-2.95 (2H, bm), 
2.87 (2H, s), 2.75-2.79 (3H, bm), 2.43 (3H, s), 2.37 (3H, s), 2.02 (lH, bs), 1.98 (3H, s), 1.73-1.79 
(2H, bm), 1.50-1.54 (2H, bm), 1.42 (2H, bm), 1.37 (6H, s), 1.18-1.26 (2H, bm), 1.07 (9H, s). 
TOCSY cross peaks (CD2Ch, 600 MHz) 8 norbomene: 6.03, 6.01 , 2.79, 2.02, 1.78, 1.52, 1.22; 
Ser: 7.54, 4.65, 2.96, 2.75; Arg: 7.38, 5.84, 4.52, 3.15, 2.92, 1.79, 1.51, 1.42; Pbf: 2.87, 2.43, 
2.37, 1.98; Asn: 7.07, 6.46, 4.37, 3.62, 3.37. 13C NMR (CDCh, 300 MHz) 8 176.40, 176.26, 
173 .98, 173 .16, 172.71 , 170.27, 170.14, 144.14, 138.53, 138.24, 137.99, 136.14, 135 .85, 132.73, 
132.36, 128.68, 127.78, 126.85, 124.44, 117.46, 86.25, 73.99, 70.95, 70.53 , 61.84, 53.53, 52.02, 
49.89, 47.40, 46.92, 46.32, 46.21, 44.41 , 43 .30, 41.57, 39.40, 37.85, 30.83 , 30.29, 29.71, 28.57, 
27.31 , 25.00, 19.28, 17.97, 12.41. IR (NaCl plate); 3434.9, 3331.1, 3061.3, 2967.9, 2926.4, 
2874.5 , 1726.4, 1643.0, 1550.0, 1492.9, 1446.2, 1394.3, 1368.4, 1332.1 , 1254.2, 1192.0, 1155.6, 
1098.6, 1031.1, 994.8, 953.3 , 901.4, 854.7, 802.8, 756.1 , 699.0, 667.9, 636.0, 621.1, 569.3 em·'. 
HRMS (DCM/NBA/NaCl) calcd for (MNa)+ 1068.4881 found 1068.4873. 
R(Pbf)-G-D(01Bu)-OH Monomer (29). The same procedure as for 24 was followed 
with R(Pbf)-G-D(01Bu)-resin (0.25 mmol, 4-carboxytrityl linker Novasyn® resin) , 251 mg (1.0 
mmol) 8, 379 mg (1.0 mmol) HBTU, 135 mg (1.0 mmol) HOBT, and 348 111 (2.0 mmol) DIEA 
in 8.3 mL DMF to yield 184 mg (82 .9%) of 29 as a white solid. HPLC: single peak at 21.90 
mm. 1H NMR (CD2Ch, 600 MHz) 8 7.97 (lH, bs), 7.61 (lH, bs), 7.19 (lH, bs), 6.37 (5H, bs), 
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5.10 (2H, s), 4.63 (1H, bs), 4.29 (1H, bs), 3.93 (lH, bs), 3.72 (lH, bs), 3.3 9 (2H, bs) , 3.16 (2H, 
bs) , 2.87 (2H, s), 2. 75 (2H, bs), 2.68-2.72 (2H, bm), 2.46 (3H, s) , 2.39 (3H, s), 2.18 (2H, bs) , 
1.98 (3H, s), 1.86 (2H, bs) , 1.73 (lH, bs), 1.58 (1H, bs), 1.50 (2H, bs), 1.36 (6H, s), 1.33 (9H, s). 
TOCSY cross peaks (CD2Ch, 600 MHz) 8 norbomene: 6.37, 5.10, 3.39, 2.18 , 1.86, 1.73 ; R : 
7.19, 6.37, 4.29, 3.16, 1.86, 1.58, 1.50; Pbf group: 2.87, 2.46, 2.39, 1.98, 1.36; G: 7.97, 3.93 , 
3.72 ; D: 7.61, 4.63 , 2.68-2.72 . 13C NMR (CD2Ch, 300 MHz) 8 177.50, 174.09, 170.68, 170.60, 
159.01 , 157.04, 138.52, 136.79, 133.13, 132.55, 128.63, 125 .17, 117.77, 86 .85, 81.75, 81.28 , 
72.75 , 70.47, 69.94, 61.44, 50.12, 47.90, 43.42, 38.12, 37.74, 32.33 , 29.07, 28.66, 28 .14, 25.76, 
23.47, 19.43, 18.14, 12.55 , 1.11. IR (NaCl plate) : 3435.3, 3331.5, 2968.3 , 2926.8, 2522.0, 
1695 .5, 1653.9, 1545.0, 1446.4, 1404.9, 1368.6, 1254.4, 1155.8, 1098.8, 1020.9, 917.2, 875.6, 
849.7, 803.0, 730.4, 657.7, 569.5 cm-1• HRMS (DCM/NBA/NaCl) calcd for (MHt 888.3813 
found 888.3778. 
S(01Bu)-R(Pbf)-N(Trt)-OH Monomer (30). The same procedure as for 24 was 
followed with S(OtBu)-R(Pbf)-N(Trt)-resin (0.25 mmol, 4-carboxytrityl linker Novasyn® resin), 
251 mg (1.0 mmol) of8, 379 mg (1.0 mmol) ofHBTU, 135 mg (1 .0 mmol) ofHOBT, and 0.348 
mL (2.0 mmol) of DIEA in 6.25 mL of DMF to yield 247 mg (85.2%) of 30 as a fluffy, white 
solid. HPLC: single peak at 26.92 min. 1H NMR (CD2Ch, 600 MHz) 8 7.58 (1H, bs), 7.51 (1H, 
bs), 7.05-7.10 (ISH, bm), 6.63 (lH, bs), 6.36 (2H, s), 5.07 (2H, s), 4.55 (lH, bs) , 4.48 (lH, bs), 
4.25 (1H, bs), 3.59 (lH, bs), 3.36-3.39 (2H,bm), 3.28-3 .32 (4H, bm), 3.00 (2H, bs), 2.68 (2H, s), 
2.80 (2H, bs), 2.42 (3H, s), 2.35 (3H, s), 1.98 (5H, s), 1.74-1.77 (2H, bm), 1.63-1.66 (lH, bm), 
1.56 (lH, bs), 1.43 (2H, bs), 1.36 (6H, s), 1.07 (9H, s). TOCSY cross peaks (CD2Ch, 600 MHz) 
8 norbomene: 6.36, 5.07, 3.36-3.39, 3.28-3.32, 1.98, 1.74-1.77, 1.63-1.66; S: 7.58, 4.55, 2.80; 
R: 7.51 , 5.84-5 .90, 4.48 , 3.00, 1.74-1.77, 1.56, 1.43 ; Pbfgroup: 2.68, 2.42, 2.35, 1.98, 1.36; N: 
6.63 , 4.25, 3.59, 3.28-3.32. 13C NMR (CD2Ch, 300 MHz) 8 180.95, 177.66, 173.33, 170.58, 
158.85 , 156.93, 144.62, 138.56, 136.73, 133.42, 132.55 , 129.04, 128.11 , 127.18, 125.42, 117.63, 
107.21, 86.72, 81.32, 74.22, 70.93 , 61.50, 47.81 , 43.46, 40.02, 38.14, 32.62, 28.65, 27.49, 25.16, 
23.57, 19.45, 18.17, 12.56, 1.11. IR (NaCl plate): 3448.4, 3341.3 , 2966.4, 2355.9, 1770.9, 
1696.0, 1679.9, 1653.1 , 1551.4, 1513.9, 1449.6, 1401.4, 1363.9, 1256.8, 1160.4, 1101.5, 1015.8, 
876.6, 855.2, 812.3, 732.0, 699.8, 662.4, 571.3 cm-1. HRMS (DCM/NBA/NaCl) calcd for 
(MNat 1181.4994 found 1181.4965 . 
Polymer Synthesis. 
General Polymer Synthesis for Polymers with one pendent amino acid or E05. 
Polymers were synthesized following a typical procedure where in a nitrogen-filled dry box, a 
solution of catalyst in was added to a solution of monomer CH2Ch (or CD2Ch for NMR 
reactions) to give an initial monomer concentration of 0.7-0.75 M. The initial [M] 0/[C]o was 
100. The reaction mixture was stirred at room temperature for 15 min to 3 h before quenching 
with ethyl vinyl ether and stirring for an additional 15-30 minutes. The polymers were 
precipitated into ether or hex, stirred for 15 min, and subjected to centrifugation. The solvent 
was removed and the solids dried under vacuum. All polymers were white to tan powders except 
for poly(21) and poly(14) which were viscous oils. Deviations from this literature procedure are 
noted in specific cases below. (Data not reported within the text is also reported below.) 
Poly(19). The reaction time was 26 h. 1H NMR (CD2Ch. 300 MHz) 8 5.40-5 .59 (trans 
& cis, 2H, bm), 3.89-4.02 (trans & cis, 2H, bm), 3.74 (trans & cis, 3H, s), 2.66 (trans & cis, 2H, 
bs), 2.48 (trans & cis, 1H, bs), 1.57-1.98 (trans & cis, 2H, bm), 1.10-1.45 (trans & cis, 2H, bm). 
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13C NMR (CD2Ch, 300 MHz): same as for Poly(20) (vide infra). IR (NaCl plate): same as for 
Poly(20) (vide infra). 
Poly(20). 1H NMR (CDCl], 400 MHz) 8 6.40, 6.03 (cis & trans, 1H, bs) , 5.18-5.55 
(trans & cis, 2H, bm), 3.88-4.08 (trans & cis, 2H, bm), 3.72 (trans & cis, 3H, s) , 3.01 , 2.65 (cis 
& trans, 2H, bs), 2.47, 2.38 (cis & trans 1H, bs), 2.17 (trans & cis, 1H, bs), 1.94, 1.84 (cis & 
trans, 1H, bs), 1.57-1.61 (trans & cis, 1H, bm), 1.15-1.20 (trans & cis, 1H, bm). 13C NMR 
(CD2Ch, 300 MHz) 8 176.12, 175.49, 171.97, 171.16, 170.79, 135.54, 134.96, 133.87, 133.04, 
131.78, 128.77, 52.46, 51.76, 51.17, 50.86, 49.43, 48.30, 43.62, 42.99, 42.36, 41.48, 37.75, 
37.55, 37.01 , 36.73, 36.36, 36.15. IR (NaCl plate): 3300.0, 3082.1 , 2947.2, 2843.4, 1752.4, 
1648.6, 1534.4, 1437.7, 1404.7, 1363 .2, 1259.4, 1202.4, 1181.6, 1031.1 , 968 .9, 844.3, 797.6, 
750.9, 704.2 em- 1• 
Poly(21). [M]o was 0.5 M. 1H NMR (CD2Cb, 400 MHz) 8 5.33-5.40, 5.18-5.25 (trans 
& cis, 2H, bm), 4.11-4.19 (trans & cis, 2H, bm), 3.51 -3.64 (trans & cis, 18H, bm), 2.69-3.07 (cis 
& trans, 2H, bm), 2.51-2.58 (trans & cis, 1H, bm), 1.78-2.40 (trans & cis, 2H, bm), 1.48-1.66 
(trans & cis, 1H, bm), 1.13-1.22 (trans & cis, 1H, bm). 13C NMR (CDCh, 300 MHz) 8 175.74, 
134.36, 133.41, 132.50, 131.92, 131.06, 128.38, 125.88, 72 .53, 70.42, 70.15, 69.07, 63.28, 61.52, 
49.92, 49.25, 47.30, 42.83, 41.85, 40.90, 36.91, 36.82. IR (NaCl plate): 3445.3, 2936.8, 2874.5, 
1726.4, 1451.4, 1347.6, 1285.4, 1249.1, 1171.2, 1114.2, 968.9, 942.9, 875.5, 854.7 em- 1. 
Poly(23). [M]o was 0.6 M. 1H NMR (CD2Ch, 300 MHz) 8 6.43-6.81 (trans & cis, 1H, 
bs), 5.08, 5.31 (trans & cis, 2H, bs), 3.93 (trans & cis, 2H, bs), 3.67 (trans & cis, 3H, bs), 2.76 
(trans & cis , 2H, bs), 2.36-2.60 (trans & cis, 2H, bm), 2.09 (trans & cis , 1H, bs), 1.82 (trans & 
cis, 1H, bs), 1.15-1.43 (trans & cis, 3H, bm). 13C NMR (CD2Ch, 300 MHz) 8 176.10, 175.98, 
171.19, 171.10, 133.66, 133.34, 132.58, 54.50, 52.66, 42.98 , 44.27, 41.70, 35.14, 32.11, 28 .23, 
28.27, 25.76, 23.19, 14.42. IR (NaCl plate): 3301.9, 3073.5, 2921.2, 2856.0, 1753.7, 1650.4, 
1536.2, 1438.3, 1405.7, 1373.1, 1210.0, 1188.2, 1035.9, 1003.3, 965.3, 845.6, 704.3, 671.6 em- 1• 
Poly(12). [M]o was 0.6 M. 1H NMR (CD2Ch, 300 MHz) 8 6.06, 5.79 (trans & cis, 2H, 
bs) , 4.92, 4.47 (cis & trans, 2H, bs), 4.60 (trans & cis, 2H, s), 4.32 (trans & cis, 2H, bs), 3.80 
(trans & cis, 2H, bs), 3.73 (trans & cis, 3H, s), 3.38 (trans & cis, 2H, bs). 13C NMR (CD2Ch, 
300 MHz) 8 176.04, 175.91 , 168.38, 155.15, 131.78, 131.49, 131.38, 81.36, 81.30, 81.24, 77.81, 
65.24, 64.07, 54.76, 54.40, 52.92, 38.30. IR (NaCl plate): 4202.5, 3631 .2, 3537.9, 3468.0, 
3013.2, 2954.9, 2850.0, 2302.0, 2197.1, 1754.6, 1707.9, 1433.9, 1393.1, 1119.1, 1031.7, 973.4, 
915.1, 850.9, 781.0, 705.2, 676.0, 629.4, 565.3 em-1. 
Poly(13). [M]o was 0.5 M. 1H NMR (CD2Ch, 400 MHz) 8 7.03 (trans & cis, 1H, bs), 
6.03, 5.79 (trans & cis, 2H, bs), 4.96, 4.48 (trans & cis, 2H, bs), 3.93 (trans & cis, 2H, bs), 3.66 
(trans & cis, 3H, s), 3.47 (trans & cis, 2H, bs), 3.37 (trans & cis, 2H, bs), 2.23 (trans & cis, 2H, 
bs), 1.85 (trans & cis, 2H, bs). 13C NMR (CD2Ch, 300 MHz) 8 176.01, 173 .21, 172.91 , 135.87, 
135 .54, 135.24, 82.46, 81.56, 81.26, 55.10, 52.57, 48.23, 41.77, 41.55, 39.16, 38.49, 34.69, 
34.21, 25.21. IR (NaCl plate): 3578.3, 3330.0, 3081.6, 2947.1, 2854.0, 1749.2, 1702.7, 1666.5, 
1542.3, 1433.6, 1397.4, 1366.4, 1211.2, 1159.4, 1118.0, 1030.1, 973.2, 916.3, 771.4, 704.1, 
564.4 em- 1• 
Poly(l4). [M]o was 0.55 M. 1H NMR (CD2Cb, 400 MHz) 8 6.05, 5.79 (trans & cis, 2H, 
bs), 4.96, 4.45 (cis & trans, 2H, bs), 4.17 (trans & cis, 2H, bs), 3.51-3 .62 (trans & cis, 20H, bm), 
3.33 (trans & cis, 2H, bs), 2.33 (trans & cis, 2H, bs), 1.86 (trans & cis, 2H, bs). 13C NMR 
(CD2Ch, 300 MHz) 8 176.33, 176.22, 173.03, 131.60, 81.37, 73.16, 70.95, 70.91, 70.70, 69.50, 
64.20, 61.98, 54.81, 52.91, 38.67, 31.79, 31.75, 23.94. IR (NaCl plate): 4016.0, 3491.3, 2908.3, 
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2302.0, 1947.0, 1777.9, 1713 .8, 1638.0, 1439.8, 833.4, 769.3, 734.3 , 705 .2, 670.2, 576.9, 512.8 
-I em. 
Poly(ll). 1H NMR (CD2Ch, 400 MHz) 8 6.06, 5.78 (trans & cis , 2H, bs) , 5.25 , 5.16 (cis 
& trans, 1H, bs) , 4.91-5.00, 4.47 (cis & trans, 2H, bm, bs), 4.29 (trans & cis , 2H, bs), 4.15-4.19 
(trans & cis, 1H, bm), 3.75 (trans & cis, 2H, bs), 3.35 (trans & cis, 2H, bs) , 1.38 (trans & cis, 
9H, s), 1.30 (trans & cis , 3H, bd, J = 7.3 Hz). 13C NMR (CDC13, 300 MHz) 8 175.42, 173 .22 , 
155 .08, 130.99, 130.89, 80.63, 79.83, 61.41 , 53.30, 52.28, 49.12, 38.20, 28.31 , 18.12. IR (NaCI 
plate) : 3528.3 , 3372.6, 2967.9, 2936.8, 2874.5, 1778.3, 1742.0, 1705 .7, 1513 .7, 1451.4, 1425.5, 
1394.3, 1363.2, 1332.1, 1249.1 , 1160.8, 1119.3, 1067.5, 1025.9, 911.8, 730.2 cm- 1• 
Poly(17). 1H NMR (CDCh, 300 MHz) 8 5.73, 5.49 (trans & cis, 2H, bs), 5.17, 5.07 (cis 
& trans, 1H, bs), 4.22-4.28 (trans & cis, 3H, bm), 3.70 (trans & cis, 2H, bm) . 2.96-3.05 (trans & 
cis, 2H, bm), 3.23 , 2.70 (cis & trans , 2H, bs), 2.05-2.27 (trans & cis, 1H, bm), 1.55-1.67 (trans 
& cis, 1H, bm), 1.40 (trans & cis, 9H, s), 1.32 (trans & cis, 3H, d, J = 7.2 Hz). 13C NMR 
(CDC13, 300 MHz) 8 177.91 , 173 .09, 155.04, 131.87, 131.75, 79.77, 61.65 , 51.65 , 50. 78, 49.12, 
47.55, 45 .59, 42.19, 40.79, 37.73, 28.32, 18_27. IR (NaCI plate): 3439.0, 3364.9, 2973.2, 
2930.9, 2867.4, 1766.8, 1745.6, 1703.3, 1512.7, 1449.2, 1422.7, 1391.0, 1364.5, 1332.8, 1248.1 , 
1163.4, 1115 .7, 1068.1 , 1020.5, 972.8, 914.6, 729.4 cm-1. 
Polymerization of RGD, SRN, and E05 Containing Polymers. 
General Polymerization Procedure. 
Method I : Same as for simple polymers as outlined above with [M]0/[C]0 = 10/1 
(homopolymers) or 20/1 (copolymers), [M]o = 0.7 M, and reaction time of 4 hr. 
Method 2: Polymers were synthesized using the following procedure where in a 
nitrogen-filled dry box, a solution of 2 in CH2Ch was added to a solution of monomer in MeOH 
(1: I CH2Ch:MeOH) in a dram to give an initial monomer concentration of 0.6 M (polymers 
containing RGD/SRN only) or 0.7 M (polymers containing E05). The dram was sealed and 
removed from the box. Within 10 min, the dram was placed in an oil bath at 55 OC and the 
solution was stirred for 2 hours. The initial [M]o/[C]o was 10/1 (polymers containing RGD 
and/or SRN only) or 20/1 (polymers containing E05). The polymerization mixtures were cooled 
to room temperature, diluted, and ethyl vinyl ether was added. The solutions were stirred for an 
additional 15-30 minutes before isolation. The polymers were precipitated into ether (26a, 31-
34), ether/CH2Ch (1 /3) (26b, 27b, 28a), ether/CHzClz (Ill) (27a) , ether/MeOH (1/3) (28b), or 
MeOH (26c). The polymers were subjected to centrifugation, the solvent was removed and the 
solids dried under vacuum. The polymers were then characterized by 1H NMR and deprotected. 
General Deprotection Procedure. For all polymers,. except 27b, the following 
procedure was observed. A solution of TF A, triisopropylsilane (TIS), and H20 (95/2.5/2.5) 
solution was added to the dried polymers to make a concentration of 20 mUg polymer. The 
mixtures were stirred for 2-7 h before precipitating into cold ether. The polymers were subjected 
to centrifugation, the solvent was removed, and the solids washed with cold ether (2 x 5 mL) 
before drying under vacuum. Polymer 27b was subjected for 1 h to 10 mL of condensed HF and 
0.5 mL of p-cresol in the proper containment apparatus. The HF was removed in vacuo and the 
solid was washed with ether before drying under vacuum. 
Solublization in Water. After deprotection, the polymers (except for 26a) were 
subjected to a minimum amount of 0.1 N NaOH for 10 min The polymers were then precipitated 
into MeOH, subjected to centrifugation, and dried under vacuum to yield the final polymers as 
tan powders (26c, 27b, 28b, 32, 33a), glassy solids (26b, 27a, 28a, 33b, 34), and a stiff gel 
(26a). 
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Specific Methods and Data. Data not reported in the text is reported below. 1H NMR 
copolymer spectrum is the addition of the homopolymer spectra. All peaks are broad. Except 
for GPC, 26b and 27a were characterized before treatment with base. 
26c. Method 2 was followed except that 3 was the initiator. 1H NMR (D20 , 400 MHz) o 
5.20-5.48 (trans & cis, 2H, bm), 4 .37 (trans & cis, 1H, bs), 3.76-3 .99, 3.60-3 .67 (trans & cis, 
4H, bm), 3.17 (trans & cis, 2H, bs), 2.84-3.02, 2.57-2.65 (cis & trans , 5H, bm), 1.63-2.01 , 1.15-
1.42 (trans & cis, 8H, bm). IR (KBr pellet): 3320.7, 2936.8, 1664.1, 1534.4, 1399.5, 1300.9, 
1249.0, 1134.9, 1025.9, 968.8, 865 .1, 750.9, 683.5, 621.2 cm- 1. 
27b. Method 2 was followed. 1H NMR (D20, 400 MHz) 8 5.24-5.49 (trans & cis , 2H, 
bm), 4.34-4.50 (trans & cis, 2H, bm), 3.79 (trans & cis, 2H, bs), 3.15 (trans & cis, 2H, bs), 2.54-
2.76 (trans & cis, 5H, bm), 1.18-1.96 (trans & cis, 8H, bm). IR (KBr pellet): 3351.9, 2926.4, 
2864.2, 1653.8, 1524.1 , 1389.2, 1306.1, 1249.1, 1197.2, 1150.5, 1083.0, 891.0, 750.9, 600.5, 
553.8 cm- 1. 
32. Method 1 was followed. (Note: The following data is for the protected polymer.) 1H 
NMR (CH2Cb, 400 MHz) o 6.06, 5.79 (trans & cis, 2H, bs), 4 .96, 4.46 (cis & trans, 2H, bs), 
4.18 (trans & cis, 2H, bs), 3.51-3 .60 (trans & cis, 4H, bm), 3.34 (trans & cis , 2H, bs), 2.89 
(trans & cis, 2H, bs), 2.35 (trans & cis, 4H, bs), 1.98 (trans & cis, 2H, bs), 1.87 (trans & cis, 4H, 
bs). 
33a. Method 1 was followed. (Note: The following data is for the protected polymer.) 
1H NMR (CH2Cb, 400 MHz) 8 6.06, 5.86 (trans & cis, 2H, bs), 4.91, 4.50 (cis & trans, 2H, bs), 
4.40-4.49 (trans & cis, 4H, bm), 3.33-3.61 (trans & cis, 4H, bm), 2.80-3 .01 (trans & cis, 4H, 
bm), 1.81-2.25 (trans & cis, 6H, bm), 1.43-1.51 (trans & cis, 2H, bm). 
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Chapter 2 




Polynorbomenes substituted with two different peptide sequences from the RGD-
containing integrin cell binding domain of fibronectin are potent inhibitors of human foreskin 
fibroblast cell adhesion to fibronectin-coated surfaces. Ring-opening metathesis polymerization 
(ROMP) using Ru=CHPh(Cl)2(PCy3)(DHIMes) (1) as an initiator produced polymers substituted 
with GRGDS and PHSRN peptide sequences. The inhibitory activity was quantified for these 
polymers and compared to the free peptides and GRGES containing controls. A homopolymer 
substituted with GRGDS peptides was significantly more active than the free GRGDS peptide 
(IC50 of 0.18 ± 0.03 and 1.33 ± 0.20 mM respectively) , and the copolymer containing both 
GRGDS and PHSRN was the most potent inhibitor (IC50 of 0.04 ± 0.01 mM). These results 
demonstrate that significant enhancements of observed biological activity can be obtained from 
polymeric materials containing more than one type of multivalent ligand and that ROMP is a 
useful method to synthesize such well-defined copolymers. 
Introduction 
In the previous chapter, the preparation of homopolymers and copolymers substituted 
with GRGD and SRN peptides using the 2,3-dihydroimidazolylidene catalyst 1 was described. 
However, these peptides represent truncated versions of the cell adhesion sequences found in 
fibronectin, and are much less active than expanded sequences GRGDS and PHSRN. 1•2 This 
chapter reports the synthesis of homopolymers and copolymers substituted with the structurally 
more complex, biologically active domains GRGDS and PHSRN. A homopolymer substituted 
with the inactive peptide GRGES 1 was synthesized and tested as a control. In addition, an 
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analysis of the polymers' biological potency for inhibiting cellular adhesion to fibronectin-coated 
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Results and Discussion 
Monomer and Polymer Synthesis and Characterization. Norbornene monomers 
substituted with oligopeptides were synthesized by solid-phase peptide chemistry. 5-
Norbornene-exo-2-carboxylic acid was coupled to the amino terminus of peptides attached to a 
4-carboxyltrityl linker resin using HBTU, HOBT and DIEA in DMF. The monomers were then 
cleaved from the resin using mildly acidic conditions to give the protected monomers. All of the 
monomers were soluble in organic solvents. In this way, norbornenes substituted with the 
protected integrin binding sequence, GR(Pbf)GD(OtBu)S(OtBu)-OH (2), synergy sequence 
PH(Trt)S(Trt)R(Pbf)N(Trt)-OH (3), and inactive sequence GR(Pbf)GE(OtBu)S(OtBu)-OH ( 4) 
were synthesized in 91%, 97%, and 47% yield respectively. While 2 and 3 were >95% pure after 
cleavage from the resin, 4 contained an impurity which appears to be partially deprotected 
monomer and which persisted in the final compound. 
Hompolymers of 2-4 and a copolymer of 2 and 3 were synthesized by ROMP using 13 as 
an initiator. The monomers were heated in a sealed vial in a 1:1 mixture of CH2Cb and MeOH 
in an oil bath at 55 ·c for 2 hours. The initial monomer concentration was 0.6 M and the initial 
monomer to catalyst ratio was 1011 . Residual monomers were removed during isolation by 
precipitation into mixtures of CH2Cb and ether. The protecting groups were then cleaved using 
either TF A or, for polymers containing PHSRN, HF to yield the unprotected peptides. The 
polymers were stirred in 0.1 N NaOH for 10 minutes to generate the sodium carboxylates. After 
isolation, the polymers were then rigorously purified by repeated centrifugation through a 
membrane (MWC0=3000) followed by lyophilization resulting in the products as spongy, tan-
colored materials. 
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In this manner, polynorbomene homopolymers substituted with GRGDS (5), PHSRN (6), 
and GRGES (7) were synthesized. The copolymer containing GRGDS and PHSRN (8) was also 
prepared. The over-all yields for the GRGDS and GRGES containing polymers were excellent 
(91% and 84% respectively). The yields of the polymers containing PHSRN were somewhat 
reduced ( 40% for 6 and 64% for 8). This could be due to the rapid degradation of 1 in the 
presence of this peptide.
4 
The percent of GRGDS incorporated into the copolymer was 49% 
(determined from the 1H NMR spectrum) which corresponded to the amount in the feed (50%). 
Table 1. Polymers substituted with oligopeptides.a 
Peptide(#) %x in feed %x in %yield 
polymerb overall 
GRGDS (5) 100% 100% 91% 12.0 1.37 
PHSRN (6) 100% 100% 40% ns ns 
GRGES (7) 100% 100% 84% 11.5 hs 
GRGDS/PHSRN (8) 50/50% 49/51% 64% 9.14 1.30 
aGeneral reactions conditions: CH2Ch:MeOH (1: I) as the solvent, 55 OC for 2 h in a sealed vial, 
[M]/[C]=I0/1 , [M] 0=0.6M. bCalculated from the 
1H NMR spectra. cDetermined by GPC, pH 8.0 
phosphate buffer eluent, poly( ethylene oxide) standards. ns =not soluble in aqueous solutions. 
hs = high molecular weight shoulder. 
Polymers 5, 7, and 8 were readily soluble in water and phosphate buffered saline (PBS). 
Unfortunately, the homopolymer substituted with PHSRN was not completely soluble in aqueous 
solutions. The number-average molecular weights (Mn) determined by GPC (compared to 
poly(ethylene glycol) standards) were between 9,100 and 12,000. The polydispersity indexes 
(PDI's) were narrow for 5 and 8 (1.37 and 1.30 respectively). The GPC trace of 7 exhibited a 
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slight high molecular weight shoulder. As mentioned above, the monomer 4 contained an 
impurity, likely the partially deprotected monomer, which could have caused the observed 
molecular weight distribution. 
Inhibitory Activity of Polynorbornenes Substituted With Oligopeptides. It was 
originally hypothesized that polymers substituted with many GRGDS peptides along the 
backbone would be more potent at inhibiting cell adhesion to fibronectin than the free peptide 
due to multivalent interactions provided by the polymer scaffold. 5•6 In addition, since PHSRN 
enhances cell binding to the RGD domain in fibronectin, 7 it was predicted that a copolymer 
substituted with both GRGDS and PHSRN would exhibit higher competitive inhibitory activity 
than materials containing only GRGDS. To investigate this, the ability of the polymers and 
peptides to inhibit HFF cell adhesion to fibronectin-coated surfaces was determined, following a 
known procedure. 1 Briefly, normal HFF neonatal cells were added to human plasma fibronectin 
coated wells containing a certain concentration of the polymer and incubated at 37 OC for 1 hour. 
The solutions were removed and the cells were fixed with methanol. The number of cells 
adopting a normal , well-spread morphology was estimated by counting a number of randomly 
selected fields viewed by phase contrast microscopy. The percent cell attachment was 
determined by comparing the experimental wells to control wells incubated with PBS alone. 
The inhibitory effects of polymers 5, 7, and 8 and peptides GRGDS, GRGES, and 
PHSRN are compared in Figure 1. As expected, GRGDS and GRGDS-containing polymers 5 
and 8 have an inhibitory effect. The inactive peptide GRGES8 as well as PHSRN, which is 
known to be inactive unless covalently bound in the vicinity of the RGD containing peptide, 7 
demonstrate no inhibitory activity. 
36 
80 








0 0.5 1 
Concentration Peptide, mM 
--e--GRGES 
~~S~~GES) 
--- Poly GRGDSIPHSRN) ==::== ~~ §~GDS) 
8 
1.5 2 
Figure 1. Inhibition of normal HDF cell attachment to fibronectin by the polymers and free 
peptides. The HDF cells (35 ,000 cells/mL) were incubated in human plasma fibronectin coated 
wells at 37 OC for 60 min in the presence of increasing concentrations of soluble peptides or 
peptide substituted polymers. Adherent cells were fixed and counted by viewing a minimum of 
6 randomly selected fields per well. Each point represents the average of 3 wells. The data for 
GRGDS peptide, Poly(GRGDS) and Poly(GRGDS/PHSRN) represents the averaged values from 
two experimental trials (as described in the text). 
The control polymer substituted with GRGES (7), an inactive peptide, 1'2 did not inhibit 
HFF adhesion to fibronectin. Cells spread normally and effectively in the presence of this 
polymer, as observed by phase contrast microscopy. This indicates that the polymer backbone is 
nontoxic to the cells, and the inhibitory effect observed for polymers 5 and 8 is due solely to the 
peptides substituted along the backbone. In addition, the percent cell attachment levels off for 
both 5 and 6 rather than continuing to decline, providing further indication that the polymers are 
nontoxic within the concentrations used for this experiment. 
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Figure 2. IC50 values for the GRGDS contammg materials. Data is reported as the 
concentration of the GRGDS (peptide) or GRGDS repeat unit (polymers) and is the mean± the 
standard error of the mean. *Within a >99.9% confidence level, this value is statistically 
different from the other two. 
The inhibitory potencies were quantified for the peptide, 5, and 8. The IC50 values, or 
concentration of GRGDS necessary to inhibit 50% of the cells from attaching, are compared 
based on the concentration of GRGDS repeat unit (polymers) or peptide as shown in Figure 2.9 
For GRGDS, an IC50 of 1.33 ± 0.20 mM was obtained, which is within the literature ranges 
obtained for this peptide.2•10 Polymer 5 has a lower IC50 of 0.18 ± 0.003 mM, and 8 is the most 
active with an IC50 of 0.04 ± 0.01 mM. These values are all statistically different from each 
other (p < 0.004 between each value). 
The inhibition experiments involving GRGDS, 5, and 8 were all duplicated in a second 
series of trial runs using peptides and polymers synthesized separately from the original batch. 
The results of these duplicate experiments fell with experimental error of the original results. 
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The data presented above for GRGDS and polymers 5 and 8 represents the averaged values from 
these two experimental series. 
Both GRGDS-containing polymers inhibited HFF adhesion to fibronectin at lower 
concentrations than did the free peptide. This indicates that multivalent peptide-integrin 
interactions provided by the polymer scaffold may be important. In addition, polymer 8 with 
GRGDS and PHSRN ligands was the most potent substrate studied. The polymer backbone 
provides the covalent linkage necessary to obtain the PHSRN-induced enhancement of RGD 
adhesive activity. 7 In fibronectin, PHSRN is 30-40 A away and on the same face of the protein 
as RGD.6 One integrin can easily span this distance. The above results indicate that the polymer 
backbone also provides the correct orientation and spatial separation of these ligands to effect an 
enhancement of GRGDS binding to the fibroblast cellular integrins. Overall, the results suggest 
that the strategy of incorporating two types of substrates into polymeric materials is a useful one 
to increase the biological activity of the resulting multidentate ligands. 
Conclusions 
These results highlight the applicability of ROMP for the synthesis of polymeric 
materials that are potent inhibitors of cell adhesion to the extracellular matrix protein fibronectin. 
Homopolymers and copolymers are readily synthesized that contain complex oligopeptide 
substituents of the RGD-integrin binding domain of fibronectin, GRGDS and PHSRN. The 
GRGDS-containing homopolymer, a multidentate ligand, was almost 750% more active in a 
competitive inhibition experiment than the GRGDS peptide. The presence of the synergistic 
peptide PHSRN, in addition to the GRGDS peptide, further enhanced the inhibitory activity; the 
copolymer was greater than 3300% more potent than the GRGDS peptide. Such materials may 
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be used to study and modulate physiologically important integrin-extracellular matrix protein 
interactions and may be useful as drugs for disease related applications such as tumor therapy. 
Experimental 
Materials. 5-Norbornene-exo-2-carboxylic acid was synthesized according to a literature 
procedure. 11 All peptide coupling agents were purchased from Novabiochem. Centriprep flasks 
were purchased from Millipore. The peptides were synthesized and purified by the Beckman 
Institute Biopolymers Synthesis Laboratory (California Institute of Technology). Methylene 
chloride used in the polymerization reactions was dried over CaH2, degassed, and vacuum 
transferred before use. All other chemicals were purchased from Aldrich and used as received. 
Dulbecco's modified eagle medium (DMEM) and all sterile cell culture reagents were purchased 
from GIBCO and used as received. The tissue culture polystyrene (TCPS) sterile flasks and 24-
well plates coated with human plasma fibronectin were purchased from Becton Dickinson 
Labware. All other sterile culture materials were purchased from Falcon. The normal human 
foreskin fibroblast (HFF) cells isolated from neonatal foreskin tissue of a single male donor were 
obtained from Clonetics. 
Techniques. All operations were carried out under a dry nitrogen or argon atmosphere. 
Dry box operations were performed in a nitrogen-filled Vacuum Atmospheres dry box. 1H NMR 
spectra were recorded on a JEOL GX-400 (399.65 MHz) or a Varian UnityPlus 600 (600.203 
MHz) spectrometer as indicated. 13C NMR (75.49 MHz) spectra were recorded on a General 
Electric QE-300 spectrometer. Chemical shifts are reported downfield from tetramethylsilane 
(TMS). Infrared spectroscopy was performed on a Perkin Elmer Paragon 1000 FT-IR 
spectrometer using a film cast on a NaCl plate or a KBr pellet as indicated. High-resolution 
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mass spectra were provided by the Southern California Mass Spectrometry Facility (University 
of California, Riverside). Aqueous gel permeation chromatography (GPC) were conducted using 
a HPLC system equipped with a Waters 515 HPLC pump, a Rheodyne model 7725 injector with 
a 200 IlL injection loop, a Waters 2487 Dual A absorbance detector, a Waters 2410 
refractometer, and two TSK columns (TASK 3000PW, TSK 5000PW). The eluent was 0.1 M 
Na2HP04 dibasic buffer, the flow rate was 1 mL!min, and poly( ethylene oxide)s were used as the 
calibration standards. The HPLC results were obtained on a Beckman 126 Solvent Module 
HPLC equipped with a 166 UV Detector and an Altech 18-LL column using a H20/CH3CN 
solvent system (7% CH3CN for 6 min, 7-90% CH3CN over 38 min, and 90% CH3CN for 8 min). 
Amino acid analysis was performed by the Beckman Research Institute in the Division of 
Immunology (City of Hope). All cell manipulations were conducted in a sterile vertical laminar 
flow hood. Phase contrast microscopy was performed on an inverted Nikon Eclipse TE300 
microscope with 200x magnification. 
Norbornene-GR(Pbf)GD(01Bu)S(01Bu)-OH Monomer (2). H2N -G-R(Pbf)-G-
D(01Bu)-S(01Bu)-resin (0.75 mmol peptide, 4-carboxytrityl linker Novasyn® resin) was placed 
in a flask containing a frit and stopcock. The resin was swelled in 20 mL of DMF for 15 min and 
the solution was removed before rinsing with DMF (1 x 10 mL). In a vial, 0.14 g (1.01 mmol) of 
5-norbornene-exo-2-carboxylic acid, 0.38 g (1.00 mmol) of 2-(JH-benzotriazole-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate (HBTU), and 0.14 g (1.04 mmol) of 1-
hydroxybenzotriazole (HOBT) in 6.6 mL of DMF were agitated until all solids had dissolved. 
N,N-diisopropylethylamine (DIEA) was added (0.35 mL, 2.01 mmol) and the solution was 
agitated before addition to the resin. Nitrogen was gently bubbled through the mixture for 2 h. 
The solution was removed, and the resin was then rinsed with DMF (5 x 10 mL), CH2Ch (5 x 10 
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mL), and MeOH (5 x 10 mL) and dried for 24 h at 30 millitorr. In a vial, 33 mL of acetic acid, 
CH2Ch, and MeOH (5 :4:1) were added to the dry resin and the vial was periodically swirled for 
1.5-2 h. The solution was filtered to remove the resin, added to an excess of hex, and the solvent 
was removed in vacuo. The procedure was repeated until all of the acetic acid was removed. 
The product was freeze-dried from benzene to give 0.73 g (91 %) of 2 as an off-white solid. 
HPLC: single peak at 21.13 min. 1H NMR (CD2Ch, 600 MHz) 6 8.09 (IH, bm), 7.58 (IH, bm), 
7.49 (IH, bm), 7.41 (IH, bm), 7.23 (1H, bm), 6.27 (IH, bm), 6.02 (1H, s), 5.98 (IH, s), 4.67 
(1H, bm), 4.43 (IH, bm), 4.32 (1H, bm), 3.88 (3H, bm), 3.77 (1H, bm), 3.67 (lH, bm), 3.54 (1H, 
bm), 3.12 (2H, bm), 2.87 (2H, s), 2.82 (IH, s) , 2.77 (1H, s), 2.73 (1H, bm), 2.66 (1H, bm), 2.45 
(3H, s), 2.38 (3H, s), 2.08 (IH, bm), 1.98 (3H, s), 1.80 (IH, bm), 1.72 (IH, bm), 1.61 (IH, bm), 
1.50 (3H, bm), 1.36 (6H, s), 1.33 (9H, s), 1.19 (2H, bm), 1.07 (9H, s) . NOESY cross peaks 
(CD2Ch, 600 MHz) 6 8.09 (G2NH), 4.32 (Ra); 7.58 (DNH), 3.88 (G2a) + 3.77 (G2a); 7.49 (RNH), 
3.88 (G1a); 7.41 (SNH), 4.67 (Da); 7.23 (G1NH), 2.08 (NorcHco). TOCSY cross peaks (CD2Ch, 
600 MHz) 6 norbomene: 6.02, 5.98, 2.82, 2.77, 2.08 , 1.72, 1.50, 1.19; G 1: 7.23, 3.88; R: 7.49, 
4.32, 3.12, 1.80, 1.61, 1.50; G2: 8.09, 3.88 , 3.77; D: 7.58, 4.67, 2.73, 2.66; S: 7.41, 4.43, 3.67, 
3.54. 13C NMR (CD2Ch, 300 MHz) 6 177.74, 173.32, 172.69, 171.15, 171.01, 158.92, 156.83 , 
138.26, 136.29, 132.52, 128.50, 125.08, 117.70, 86.79, 82.09, 74.13, 70.78, 61.69, 50.37, 47.65, 
46.57, 44.39, 43.76, 42.06, 40.87, 37.84, 30.85 , 29.48, 28.74, 28.21 , 27.93 , 27.51 , 25 .94, 19.54, 
18.25, 12.66. IR (NaCl plate): 3320.7, 3061.2, 2967.8, 2926.3, 2864.1, 1726.4, 1653.7, 1544.8, 
1456.6, 1363.2, 1249.0, 1155.6, 1098.5, 953.3, 849.5, 808 .0, 709.4, 667.9, 564.1 cm- 1• HRMS 
(DCM/NBA/PPG) calcd for (MHt 975.4861, found 975.4876. 
Norbornene-P-H(Trt)-S(Trt)-R(Pbf)-N(Trt)-OH Monomer (3). The same procedure as for 2 
was followed with H2N-P-H(Trt)-S(Trt)-R(Pbf)-N(Trt)-resin (0.75 mmol, 4-carboxytrityl linker 
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Novasyn® resin), 0.14 g (1.01 mmol) of norbornene-exo-2-carboxylic acid, 0.38 g (1.00 mmol) 
of HBTU, 0.14 g ( 1.04 mmol) of HOBT, and 0.35 mL (2.0 I mmol) of DIEA in 6.3 mL DMF to 
yield 1.24 g (97.3%) of 3 as a fluffy white solid. HPLC: single peak at 38.85 min. 1H NMR 
(CD2Ch, 600 MHz) 8 8.29 (IH, bm), 7.59 (IH, bm), 7.47 (IH, bm), 6.89-7.29 (48H, bm with 
max. at 6.89, 7.04, 7.13 , 7.22, 7.28, 7.29), 6.63 (IH, bm), 5.98 (2H, bm), 5.84 (IH, bm), 4.45 
(IH, bm), 4.13-4.30 (4H, bm), 3.36-3.47 (4H, bm), 2.65-2.93 (IOH, bm), 2.40 (3H, s), 2.34 (3H, 
s), 1.54-2.08 (13H, bm with max. at 1.54, 1.63 , 1.76, 1.98, 2.10), 1.34 (7H, bm), 1.22 (2H, bm). 
13C NMR (CD2Ch, 300 MHz) 8 175.65, 174.74, 174.27, 172.87, 172.10, 171.27, 170.01 , 158.49, 
156.70, 144.51 , 143.85, 141.86, 138.37, 138.12, 136.19, 135.91 , 132.32, 129.90, 128.83, 128.49, 
128.42, 128.06, 127.91 , 127.32, 127.11, 126.92, 124.62, 120.31 , 117.34, 87.20, 86.49, 70.66, 
63.49, 61.24, 54.93 , 51.09, 47.78, 46.95 , 46.24, 45.79, 43.51, 43.07, 42.76, 41.98, 41.90, 30.81 , 
30.33 , 30.06, 29.62, 28.70, 25.35 , 25.26, 21.26, 19.51 , 18.20, 12.68. IR (NaCl plate) : 3317.7, 
3054.7, 2970.5 , 2917.9, 1669.8, 1622.5, 1548.8, 1491.0, 1443.6, 1264.8, 1154.3 , 1096.4, 1033.3, 
896.5, 738.7, 696.6 em·'. HRMS (MALDI) calcd for (MNat 1708.7737, found 1708.7739. 
Norbornene-G-R(Pbf)-G-E(01Bu)-S(01Bu)-OH (4). The same procedure as for 2 was 
followed with H2N-G-R(Pbf)-G-E(0
1Bu)-S(01Bu)-resin (0.25 mmol, 4-carboxytrityl linker 
Novasyn® resin) , 0.14 g (1.01 mmol) of 5-norbomene-exo-2-carboxylic acid, 0.38 g (1.00 mmol) 
of HBTU, 0.14 g (1.04 mmol) of HOBT, and 0.35 mL (2.01 mmol) of DIEA in 6.6 mL DMF to 
yield 0.11 g ( 46.1 %) of 4 (plus an impurity detected in the 1H NMR spectrum) as a white solid. 
HPLC: single peak at 24.35 min. 1H NMR (CD2Ch, 600 MHz) 8 8.07 (IH, bm), 7.53-7.62 (3H, 
bm), 7.23 (IH, bm), 6.23-6.28 (2H, bm), 6.02 (IH, s), 5.99 (IH, s), 4.42 (1H, bm), 4.25-4.28 
(2H, bm), 3.79-3.86 (4H, bm), 3.68 (IH, bm), 3.56 (IH, bm), 3.11 (2H, bm), 2.86 (2H, s), 2.82 
(IH, s), 2.77 (IH, s), 2.46 (3H, s), 2.39 (3H, s), 2.36 (IH, bm), 2.30 (IH, bm), 2.08 (IH, bm), 
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1.98 (3H, s) , 1.93 (2H, bm), 1.80 (lH, bm), 1.73 (1H, bm), 1.61 (lH, bm), 1.50 (3H, bm), 1.36 
(6H, s), 1.33 (9H, s), 1.19 (2H, bm), 1.06 (9H, s). IR (NaCl plate): 3286.2, 2970.6, 1727.7, 
1627.8, 1543.6, 1448.9, 1364.7, 1249.0, 1154.3 , 1096.4, 733.4, 665.0, 570.3 cm- 1• HRMS 
(DCM/NBA/PPG) calcd for (MHt 989.5018, found 989.5018. 
General Polymerization Procedure. In a nitrogen-filled dry box, a solution of 1 m 
CH2Ch was added to a solution of monomer in MeOH (to achieve 1:1 CH2Ch:MeOH) contained 
in a dram to give an initial monomer concentration of 0.6 M. The dram was sealed and removed 
from the dry box. Within I 0 min, the dram was placed in an oil bath at 55 OC and the solution 
was stirred for 2 h. The initial monomer to catalyst ratios were 10/ 1. The polymerization 
mixtures were cooled to room temperature, diluted, and ethyl vinyl ether was added. The 
solutions were stirred for an additional 15-30 min before isolation by precipitation into 
CH2Ch:ether (3: 1 for 5-7, 1: I for 8). The polymers were subjected to centrifugation, the solvent 
was removed, and the solids dried under vacuum. 
General Deprotection Procedure. For 5 and 7, a solution of TF A, triisopropylsilane 
(TIS), and H20 (95/2.5/2.5) was added to the dried polymers to make a final concentration of 20 
mUg polymer. The mixtures were stirred for 2.5 h before precipitation into cold ether. The 
polymers were subjected to centrifugation, the solvent was removed, and the solids washed with 
cold ether (2 x 5 mL) before drying under vacuum. Polymers 6 and 8 were subjected for I h to 
10 mL of condensed HF and 0.5 mL of p-cresol in the proper containment apparatus. The HF 
was removed in vacuo and the solid was washed with cold ether before drying under vacuum 
Purification. The polymers were subjected to a minimum amount of 0.1 N NaOH for 10 
min, precipitated into MeOH, isolated by centrifugation, and dried under vacuum. Deionized, 
doubly distilled water was added to the polymers and the polymers purified by centrifugation 
44 
through a membrane using Centriprep tubes with a molecular weight cut off (MWCO) of 3000. 
This procedure was repeated a minimum of 5 times for each polymer. The polymer solutions 
were then subjected to centrifugation, the solution decanted to remove any insoluble particulate 
material, and lyophilized. The resulting polymers were all spongy, tan materials and were kept 
at -30 OC until use. 
The polymers were characterized and the data not reported in the text is reported below. 
The 1H NMR copolymer spectrum is the addition of the two homopolymer spectra. All peaks 
unless otherwise stated, are the composite of the trans and cis polymer proton peaks. 
GRGDS Homopolymer (5). 1H NMR (D20, 400 MHz): 8 7.33 (NH, bm), 5.34 (2H, 
bm), 3.82-4.32 (7H, bm with max. at 3.82, 3.94, 4.23), 2.58-3.22 (7H, bm with max. at 2.62, 
2.68, 3.16), 1.19-1.87 (8H, bm with max. at 1.61, 1.73, 1.87). IR (KBr pellet): 3363.1, 2933.3, 
1638.7, 1528.6, 1397.6, 1240.4, 1114.6, 1036.0, 967.9, 925 .9, 611.5 cm- 1• AAA expected 
(found): Asp 1.00 (1.03), Ser 1.00 (0.90), Gly 2.00 (1.96), Arg 1.00 (1.11) residue/mol. 
GRGES Homopolymer (7). 1H NMR (D20, 400 MHz): 8 7.30 (NH, bm), 5.34 (2H, 
bm), 3.79-4.31 (8H, bm with max. at 3.79, 3.92, 4.21 , 4.31), 2.54-3.13 (5H, bm with max. at 
2.54, 3.13), 1.09-2.20 (12H, bm with max. at 1.55, 1.85, 2.08, 2.20). IR (KBr pellet): 3323 .8, 
2936.0, 1655.7, 1540.4, 1451.3, 1398.9, 1241.7, 1115.9, 1042.5, 979.7, 848.6, 670.5, 539.5 cm- 1• 
AAA expected (found): Ser 1.00 (1.04), Glu 1.00 (1.09), Gly 2.00 (2.15), Arg 1.00 (0.72) 
residue/mol. 
GRGDS/PHSRN Copolymer (8). 1H NMR (D20, 400 MHz): 8 7.62, 7.22, 6.92, 5.33, 
4.14-4.43 (with max. at 4.22, 4.35, 4.43), 3.74-3.92 (with max. at 3.81, 3.92), 3.12, 2.61, 1.16-
2.13 (with max. at 1.58, 1.71, 1.85). IR (KBr pellet): 3342.1, 2933.3, 1596.7, 1444.8, 1387.1, 
1313.7, 1245.6, 1046.5, 983.6, 925.9, 616.7 cm- 1• AAA expected (found): Asp+ Asn 2.00 
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(2.04), Ser 2.00 (1.73), Pro 1.0 (1.07), Gly 2.00 (2 .24) , His 1.0 (0.97) , Arg 2.00 (1 .94) 
residue/mol. 
Cell Maintenance. HFF cells were maintained in DMEM supplemented with 10% fetal 
bovine serum, 400 U/mL penicillin, and 400 mg/mL streptomycin in an incubator at 37 OC and 
4.9% C02. Subculturing was accomplished by rinsing the cells with HEPES buffered saline 
solution (HBSS), enzymatically removing the cells from the surface with trypsin, and 
neutralizing the trypsin with supplemented DMEM. The number of viable cells was assessed 
using a hemacytometer with trypan blue, and the cells were dispensed into 25 or 75 cm2 flasks at 
a density of 3500 cells/cm2. 
Sample Preparation. Samples were weighed on a microbalance and solubilized in 
phosphate buffered saline (PBS) to a concentration 4x the desired final concentration. The pH of 
the solutions were determined and adjusted to ~ 7.4 as necessary. Phosphate buffered saline 
(PBS) alone was used in the control wells. The samples were filter (0.2 ~-tm) sterilized before 
use. 
Competitive Inhibition Assay. To 24-well plates coated with human plasma 
fibronectin, 100 ~-tl of the polymer or peptide solutions or PBS alone (control) was added. HFF 
cells of passage 4-7 were harvested with trypsin as described above and resuspended to 35,000 
cells/mL in unmodified DMEM. Cell suspensions were allowed to recover for at least 15 min 
before adding 300 ~-tl to each well. The cells were evenly dispersed by gentle rocking ofthe plate 
before incubation for 60 min at 37 OC and 4.9% C02. The attached cells were fixed with 
methanol after removal of the sample solutions and washing with deionized H20. The cells were 
observed by phase contrast microscopy and counted in a minimum of 6 randomly selected fields 
per well. The percent maximum cell attachment is the average number of cells per view divided 
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by the average number obtained for the control multiplied by 100. The IC50 is the concentration 
where 50% of the maximum possible cells are attached, reported and the mean± standard error 
of the mean. The p values were determined by nonparametric unpaired two group analysis using 
S V
. ® 
tat 1ew . 
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